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ABSTRACT OF THE DISSERTATION 
Biogenetically Inspired Total Synthesis of Lingzhiol.  
Design and Synthesis of Axially Chiral N-Heterocyclic Carbene Catalysts.  
 
for Arts & Sciences Graduate Students 
by 
Krishna P. Sharmah Gautam 
Washington University in St. Louis, 2016 
Professor Vladimir B. Birman, Chair 
 
A stereo- and enantio-selective synthesis of lingzhiol has been achieved, mimicking a 
proposed biogenetic pathway via Brønsted acid-catalyzed semipinacol rearrangement of a 2,3-
epoxy alcohol. 
 A new and improved method was developed for alkylation of anilines using a domestic 
microwave oven. The resulting racemic chiral anilines were resolved via classical resolution and 
transformed into axially chiral thiazolylidene-based NHC organocatalysts, which were applied to 
asymmetric benzoin condensation.  
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CHAPTER 1: Lingzhiol 
1.1 Introduction. 
Lingzhiol (1.01) is a meroterpenoid isolated from mushroom Ganoderma Lucidum by 
Cheng et al. in 2013.1a The mushroom, also known as ling-zhi in Chinese, is widely used in 
traditional Chinese medicine. It possesses a unique propellane-shaped structure. Somewhat 
unusually for naturally occurring organic compounds, it exists as a racemate. According to 
preliminary studies by Cheng et al., both of its enantiomers, separated via semipreparative HPLC, 
showed comparable inhibitory activity towards phosphorylation of the SMAD3 transcription 
protein, which is relevant in the pathogenesis of renal fibrosis.1a Although extraction of lingzhiol 
from the mushroom was adequate for the initial studies, its content is very low (about 1 ppm in 
dry ling-zhi). Thus, a concise and flexible synthetic route to this molecule is necessary for further 
pharmacological studies and exploration of its unnatural analogs. 
 
Figure 1.1: (a) Structure of lingzhiol. (b) Ling-zhi mushroom. 
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1.2 Cheng’s proposed biosynthesis of lingzhiol. 
Meroterpenoids are complex oxygenated natural products derived from polyketide and 
terpenoid precursors. Cheng et al.1 proposed that the biosynthesis of lingzhiol proceeds via fornicin 
A 1.02, as shown in Figure 1.2. According to their proposal, hydrolysis of the butenolide and 
allylic oxidation leads to carbocation 1.03, which undergoes intramolecular electrophilic addition 
to cyclic hydroxy acid 1.04. Loss of methyl group (presumably via oxidation) yields zwitterionic 
intermediate 1.05, which undergoes intramolecular cyclization and benzylic oxidation to generate 
6/6/5 tricyclic product 1.06. Further oxidation of the remaining methyl group forms unsaturated 
hydroxy acid 1.07, followed by lactonization produces tetracyclic unsaturated intermediate 1.08, 
which undergoes hydration would lead to lingzhiol 1.01. 
OH
OH O
OH
OH
O
1.02, Fornicin A
Me
Me
OHO
OH
OH
OH OH
HO
O
OH
OH OH
HO
O
-CH3
1.03
1.04 1.05
OH
OH O
CO2H
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[O]
[O]
OH
OH O
CO2H
1.07
O
O
OOH
OH
O
O
OOH
OH
HO
1.08 1.01
MeMe Me Me
OH
Me
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Figure 1.2:  Cheng’s proposed biosynthetic pathway.  
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1.3 Reported total syntheses of lingzhiol.  
 So far, five total syntheses of lingzhiol have been reported including our own. Two 
syntheses appeared in the literature prior to ours. Three of the published syntheses, which employ 
strategies different from ours, are discussed below.  
1.3.1 Long and Huang’s synthesis.  
In 2014, Long and Huang2 reported the first asymmetric total synthesis of lingzhiol. Their 
synthetic scheme is shown in Figure 1.3. They started with 5,8-dimethoxy tetralone 1.09, which, 
upon Wittig olefination followed by a ring expansion with Koser’s reagent in the presence of p-
toluenesulfonic acid, provided ketone 1.10. Compound 1.10 underwent aldol condensation with 
Eschenmoser’s salt to give the corresponding enone, which was subjected to asymmetric reduction 
with (R)-Corey-Bakshi-Shibata (CBS) reagent to enantioenriched allylic alcohol 1.11. This was 
subjected to substrate controlled epoxidation with m-CPBA, then oxidized to ketone 1.12 with 
Dess-Martin periodinane (DMP). The epoxy ketone 1.12 was reacted with methyl cyanoformate 
to produce the β-keto ester, which was reacted with Waser’s reagent (A) in presence to tetra-n-
butylammonium fluoride to afford compound 1.13. This intermediate was deoxygenated with NaI 
in the presence of trifluoroacetic acid, and then reduced under Luche’s conditions to produce 
homo-propargyl alcohol 1.14. The alcohol underwent rhodium-catalyzed [3+2] cycloaddition that 
introduced two quaternary carbon centers at its bridgehead carbons giving tricycle 1.15 (see 
below). Further treatment of 1.15 with NaBH4 resulted in lactonization, which was followed by 
allylic oxidation with selenium dioxide and palladium catalyzed hydrogenation to give compound 
1.16. Its benzylic oxidation was achieved via a one-pot sequence involving radical-mediated 
halogenation with NBS in presence of benzoyl peroxide (BPO), hydrolysis of the intermediate 
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bromide and subsequent oxidation of the benzyl alcohol with MnO2. Finally, demethylation of the 
two methoxy groups in the presence of AlCl3 and excess t-BuSH produced lingzhiol 1.01. 
 
Figure 1.3: Long and Huang’s synthesis of lingzhiol.  
 Although the synthesis is relatively long, it features an elegant method to construct the 
[3.3.0] bicyclic system with vicinal stereogenic quaternary carbon centers via a rhodium catalyzed 
intramolecular [3+2] cycloaddition. The mechanism of this transformation proposed by the authors 
is shown in generic form in Figure 1.4. The rhodium (I) catalyst reacts with 1.17 to produce 
complex (I), which undergoes retro-propargylation to give complex (II). Its subsequent 
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rearrangement via intramolecular Michael addition of the allenylrhodium to the enal results in 
complex (III).  Conia-ene type cyclization of the alleno enolate species (III) produces bicyclic 
carbocycle (IV). Its alcoholysis affords aldehyde 1.11 and regenerates complex (I) that enters into 
the next catalytic cycle. 
OH
HRO
n
CHO
n
[Rh(1)LnCl]
CHO
OR
n
Alcoholysis
RO Rh(I)Ln
OH
HRO
n
HCl
RO H
O
Rh(I)Ln
Retropropargylation
Michael addition of
alleno rhodium to enal
Conia-ene type reaction
of enolate toward allene
Alcoholysis
1.17
(I)
(IV)
1.17
1.18
C
RO H
O
n
Rh(I)Ln
(II)
n = 1,2
C
RO H
O
n
Rh(I)Ln
(III)  
Figure 1.4: Proposed rhodium catalyzed (3+2) cycloaddition. 
1.3.2 Qin’s first synthesis. 
 In 2015, Qin et al.3a reported a racemic synthesis of lingzhiol, shown in Figure 1.5. 
Alkylation of ketoester 1.20 with 2-arylethyl iodide 1.19 provided 1.21. Grignard addition and 
dehydration produced 1.22 as a mixture of exo and endo isomers. While the exo-isomer was 
converted into allylic alcohol 1.23 in one step via selenium dioxide oxidation, the endo-isomer 
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required four additional steps. Sharpless epoxidation of 1.23 afforded epoxy ester 1.24.  Under 
Lewis acid mediation, compound 1.24 was rapidly converted to an advanced intermediate lactone 
1.16 via tandem epoxy-arene cyclization/lactonization. Lactone 1.16 was converted to racemic 
lingzhiol 1.01, using the protocol previously used by Long and Huang2 for benzylic oxidation and 
BBr3 for demethylation. 
O
O
HO
O
MeO
MeO
O
HO
(±)-1.01
OOH
OH11. NBS, BPO
12. MnO2
(50%)
13. BBr3 (60%)
1.16
MeO
MeO
I
9. VO(acac)2
(90%)
MeO
MeO
CO2Et
OH
1.19
1.23
O
CO2Et
K2CO3, DMF (78%)
1.
2. MeMgI (95%)
3. NEt3, SOCl2 (80%)
MeO
MeO
CO2Et
1.22-endo
MeO
MeO
CO2Et
1.22-exo
+
MeO
MeO
1.21
O
8. SeO2
TBHP
(65%)
4. OsO4, NMO 5. Ac2O, Py (68% in two steps)
6. Et3N, SOCl2 7. K2CO3, MeOH/H2O (85% in two steps)
CO2Et
MeO
MeO
OH
10. BF3.Et2O
(75%)
O
1.24
O
OEt
epoxy-arene
cyclization/
lactonization
1.20
 
Figure 1.5: Qin’s first synthesis of lingzhiol. 
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1.3.3 Qin’s second synthesis. 
 In 2016, Qin et al.3b reported another synthesis of lingzhiol, illustrated in Figure 1.6, this 
time using a different strategy and leading to the final product in enantiopure form. They started 
by alkylating ketoester 1.20 with bromo-dioxolane 1.25. Kinetic resolution of the resulting racemic 
ketone via chemoenzymatic reduction with baker’s yeast provided highly enantiopure 
hydroxyester (S)-1.26. Its oxidation with PCC, followed by Wittig olefination and selenium 
dioxide oxidation provided unsaturated ketoester 1.27. This was transformed into 1.28 in two steps 
via addition of m-methoxyphenyllithium to the enone carbonyl followed by Sharpless epoxidation. 
On treatment with TMSOTf, this intermediate underwent Lewis acid-mediated tandem 
semipinacol rearrangement/lactone formation via 1, 2- aryl group migration onto an epoxide ring 
to give 1.29, followed by Friedel-Crafts cyclization (1.30) and elimination (1.31) to obtain 
dihydronaphthalene 1.32. Compound 1.32 was converted into bromohydrin with NBS, and further 
oxidized to bromoketone 1.33. Reductive removal of bromine, followed by chemo- and 
stereoselective reduction of the dialkyl ketone and Baeyer-Villiger oxidation of the arylketone with 
m-CPBA afforded aryl ester 1.34. In a one pot synthesis, the aryl ester was treated with K2CO3 in 
MeOH to form the methyl ester and the intermediate phenolate formed during the methanolysis 
attacked the alkyl lactone (shown in 1.35) to form the dihydrofuran ring. Acetylation of the 
unprotected secondary alcohol (cf. 1.36), followed by a meta-Fries rearrangement with TFAA in 
TFA, accompanied by migration of the methoxy group via intermediate 1.37, provided 
dihydrobenzofuran 1.38. Global deprotection of 1.38 with BBr3 provided (+)-1.01.  
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Figure 1.6: Qin’s second synthesis of lingzhiol. 
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1.4  Our synthesis of lingzhiol. 
1.4.1 Our proposed biosynthesis. 
In contrast to Cheng’s biosynthetic proposal,1 we4 envisioned an alternative biosynthetic 
pathway shown in Figure 1.7. We hypothesized that meroterpenoid 1.39, the presumed 
biosynthetic precursor to fornicin 1.02 shown in Figure 1.2, would undergo a series of oxidations 
and cyclizations to give putative intermediate 1.40. Its oxidation and decarboxylation would then 
lead to glycidol intermediate 1.41, which would undergo acid-catalyzed semipinacol 
rearrangement (cf. 1.42) to generate aldol 1.43. Afterwards, reduction of the aldehyde in 1.43, 
followed by lactonization, would complete the biosynthesis of lingzhiol 1.01. 
 
Figure 1.7: Our proposed biosynthesis of lingzhiol.  
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1.4.2 Precedents for semipinacol rearrangement. 
There are several literature precedents for Lewis acid-mediated semipinacol rearrangement 
of protected and unprotected epoxy alcohols into aldols (cf. structure 1.42, Figure 1.7). In 1989, 
Marouka et al.5 reported that the bulky methylaluminium bis(4-bromo-2,6-di-t-butylphenoxide) 
1.44 mediated the rearrangement of epoxy silyl ether 1.45 into β-siloxy aldehyde 1.46. The 
observed stereoselectivity is due to the migration of the siloxyalkyl group anti- to the epoxide 
moiety (Figure 1.8). 
 
Figure 1.8: Semipinacol rearrangement by Maruoka and Yamamoto. 
In 2003, Tu et al.6 reported triethylaluminum-mediated semipinacol rearrangement of 
unprotected 2,3-epoxyalcohol 1.47 into syn-aldol 1.48 via C—C bond migration which further 
reduced to diol 1.49, shown in Figure 1.9. 
 
Figure 1.9: Triethylaluminum mediated semipinacol rearrangement. 
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Also in 2003, Zhao et al.7 reported samarium iodide-mediated semipinacol rearrangement 
of unprotected epoxy alcohol 1.50 to syn-aldol 1.51 as shown in Figure 1.10. 
 
Figure 1.10: Samarium iodide catalyzed semipinacol rearrangement. 
In 2008, Zhang et al.8 reported a titanium chloride-mediated tandem process based on the 
semipinacol rearrangement and Schmidt reaction of 1.52 to 1.53 in the total synthesis of (±) 
stemonamine 1.54 as shown in Figure 1.11. 
 
Figure 1.11: Titanium chloride-mediated tandem semipinacol rearrangement/Schmidt reaction. 
1.4.3 Our retrosynthetic analysis. 
 As shown in Figure 1.12, lingzhiol 1.01 could be synthesized from the same advanced 
intermediate 1.16 reported by Long and Huang2 following their protocol used for benzylic 
oxidation and demethylation. Guided by our biosynthetic hypothesis for lingzhiol, we envisioned 
that 1.16 could be constructed via Brønsted or Lewis acid-catalyzed semipinacol rearrangement of 
the glycidol intermediate 1.56, followed by reductive lactonization of syn-aldol 1.55. Intermediate 
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1.56 could be synthesized from 5,8-dimethoxytetralone 1.09, the starting material employed by 
Long and Huang2 via a sequence of standard synthetic transformations: Claisen condensation, 
Robinson annulation, stereoselective ketone reduction and epoxidation.  
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Figure 1.12: Our retrosynthetic analysis of lingzhiol. 
 
1.4.4 Stereoselective synthesis. 
 According to our retrosynthetic analysis, 5,8-dimethoxy tetralone 1.09 is a viable starting 
material, but an expensive one. We, therefore, decided to synthesize it following the protocol 
published by Wipf and Jung9. As shown in Figure 1.13, 1,4-dimethoxybenzene 1.59 was acylated 
with succinic anhydride 1.60 via Friedel-Crafts acylation in the presence of aluminum chloride 
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and afforded keto acid 1.61 in 50% yield. Compound 1.61 was reduced via Wolff-Kishner 
reduction to acid 1.62 in 59% yield, which was cyclized to 5-8-dimethoxytetralone 1.09 in 66% 
yield. 
 
Figure 1.13: Preparation of 5,8-dimethoxytetralone 1.09. 
As shown in Figure 1.14, dimethoxytetralone 1.09 was subjected to Claisen condensation 
with dimethyl carbonate, following a protocol developed by Johnson and Mander,10 to afford 
ketoester 1.63 in a quantitative yield. Michael addition with methyl vinyl ketone (MVK) catalyzed 
by 1,1′,4,4′-tetramethylguanidine (TMG) afforded diketoester 1.64 in 79% yield. Treatment with 
sodium methoxide as a base converted it into tricyclic enone 1.65, thus completing the classical 
Robinson annulation11. 
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Figure 1.14: Preparation of tricyclic enone 1.65. 
  Stereoselective reduction of tricyclic enone 1.65 was investigated next (Figure 1.15). 
Under Luche’s conditions12 at 0° C, the desired syn-allylic alcohol 1.66 was obtained with only 
4:1 selectivity. However, their ratio was increased to 9:1, when the reaction was carried out at 
lower temperature (-78 °C to 0 °C).  
 
Figure 1.15: Preparation of tricyclic allylic alcohol 1.66. 
According to our original plan, (±)-1.66 would be epoxidized and the resulting syn-glycidol 
intermediate 1.68 would be subjected to the Lewis acid-mediated semipinacol rearrangement using 
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previously reported conditions. However, when 1.66 was treated with m-CPBA in CDCl3 at room 
temperature, 1H NMR of the reaction mixture indicated the presence of not only the expected 
glycidol (±)-1.68, but also two sizeable aldehyde peaks in 11:1 ratio attributed to the 
diastereomeric aldols (±)-1.69 and (±)-1.71, shown in Figure 1.16.  We surmised that the 
spontaneous semipinacol rearrangement was facilitated either by m-chlorobenzoic acid or 
adventitious DCl present in the solvent. Addition of 20 mol% of trifluoroacetic acid (TFA) 
completed the rearrangement within thirty seconds. The unprecedented ease with which it took 
place was rationalized by the perfect overlap of the π-system of the benzene ring with the 
carbocation formed during the epoxide opening. The fact that some anti-aldol (±)-1.71 formed, in 
contrast to the completely stereoselective semipinacol rearrangements discussed above (Figures 
1.7-1.9) was explained by the acid-catalyzed retroaldol-aldol epimerization of the initially formed 
syn-diastereomer proceeding via the open-chain intermediate (±)-1.70. Indeed, on prolonged 
standing in the acidic reaction mixture, or during attempted purification via flash column 
chromatography, the thermodynamically favored anti-aldol (±)-1.71 began to predominate.  
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Figure 1.16: Epoxidation and semipinacol rearrangement. 
To minimize the epimerization, we found it advantageous to reduce the crude aldol mixture 
immediately after the rearrangement, by treatment with sodium borohydride (Figure 1.17). The 
desired lactone (±)-1.16, which served as an advanced intermediate in the two previous syntheses 
of lingzhiol,2,3 was produced in diastereomerically pure form in 56% yield. Surprisingly, none of 
the epimeric lactone was obtained, unreacted anti-aldol (±)-1.71 being recovered in 18% yield 
after chromatographic separation. Overall, 26% isolated yield of the lactone (±)-1.16 in six steps 
from the commercially available 5,8-dimethoxytetralone 1.09 compared favorably to the two 
previously published synthetic routes.2,3  
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Figure 1.17: Preparation of lactone 1.16. 
 At this stage, the formal synthesis of lingzhiol (±)-1.01 was completed, but we decided to 
complete the total synthesis of the natural product in order to study its biological activity. One-pot 
benzylic oxidation sequence described by Long and Huang2 and later used by Qin et al.3a did not 
produce any of the expected product. Several other methods for direct benzylic oxidation such as 
N-hydroxyphthalimide (NHPI) and sodium chlorite,13 pyridinium dichromate (PDC) and t-
butylhydroperoxide14 were also unsuccessful. Aerobic oxidation with NHPI and manganese (II) 
acetate,15 NHPI and cobalt (II) acetylacetonate,16 NHPI and copper (II) chloride17 were 
investigated, and in all cases the reactions were extremely slow, producing ca.10% conversion in 
48 hours. Direct oxidation of the unprotected lactone 1.16 with 3,5-dimethylpyrazole and 
chromium trioxide18 and aerobic oxidation with NHPI and AIBN19 afforded the expected product 
(±)-1.74, along with undesired products resulting from oxidation of the unprotected alcohol and 
overoxidation of the product. Thus, we decided to perform the benzylic oxidation via the three step 
sequence shown in Figure 1.18: (a) protection of the alcohol group (b) aerobic benzylic oxidation 
and (c) deprotection of the alcohol.  Aerobic benzylic oxidation of the protected intermediate 1.72 
with catalytic amount of NHPI/AIBN proceeded in an acceptable 50% yield of 1.73, thus providing 
access to the known O,O-dimethyl-lingzhiol 1.74.  
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Figure 1.18: Preparation of O,O-Dimethyl-lingzhiol 1.74. 
 As shown in Figure 1.19, when compound (±)-1.74 was subjected to demethylation with 
BBr3 as described by Qin et al.3a only monodemethylation to (±)-1.75 was observed. Treatment 
with excess BBr3 resulted in a complex mixture of products. Fortunately, Long and Huang’s 
original protocol,2 requiring the use of t-butylmercaptan as the solvent, worked almost as well as 
reported and afforded racemic lingzhiol (±)-1.01 in 58% yield. 
 
Figure 1.19: Preparation of racemic lingzhiol 1.01. 
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1.4.5 Asymmetric synthesis. 
The synthesis of lingzhiol discussed above could be easily rendered asymmetric by 
employing an enantioselective catalytic version of the Michael addition of β-ketoester 1.63 to 
MVK in the second step (see Figure 1.14). Although many types of Michael additions, including 
those of cyclic β-ketoesters to enones, have been achieved with high enantioselectivity,20 we have 
found few encouraging close precedents for our specific case.  Indeed, while 1-indanone-2-
carboxylate20(b-f) and cyclohexanone-2-carboxylate20(f-i) esters and have been added to MVK or 
related β-unsubstituted Michael acceptors with over 90% ee under a variety of conditions, the 
seemingly very similar 1-tetralone-2-carboxylate esters have been conspicuously absent from most 
lists of substrates or even explicitly stated to produce poor results. In fact, we were able to find 
only one successful example that would fit our bill. 
 In 2006, Kobayashi et al.21 reported that the scandium (III) triflate complex with C2-
symmetrical 2,2’-bipyridine ligand 1.78 developed originally by Bolm et al. catalyzed the 
conjugate addition of 1.76 to ethyl vinyl ketone 1.77 with 92% ee (Figure 1.20). Alas, Bolm’s 
ligand was commercially unavailable. We decided to obtain it by a modification of the two 
published procedures for its synthesis,22 which both rely on the reductive coupling of enantiopure 
alcohol 1.81 in the last step (Figure 1.21). While the literature syntheses for this intermediate call 
for the asymmetric reduction of the corresponding ketone 1.81, we anticipated that we may need 
access to both of its enantiomers. Therefore, we felt it would be advantageous to prepare its 
racemate in a single step and then resolve it. The structure of alcohol 1.81 suggested that it would 
be a good substrate for the acylative kinetic resolution promoted by amidine-based catalysts 
(ABCs) developed earlier in our group (Figure 1.22).23  
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Figure 1.20: Precedent for the proposed enantioselective Michael addition step. 
 
Figure 1.21: Bolm’s original (A) and Kobayashi’s improved (B) syntheses of Bolm’s ligand. 
 
Figure 1.22: Preparation of Bolm’s ligand via kinetic resolution. 
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Table 1.1: Optimization of kinetic resolution conditions for (±)-1.81. 
Serial Solvent 
[M] 
Catalyst 
(mol%) 
Conversion 
% 
Time 
(hr) 
Alcohol 
(ee%) 
Ester 
(ee%) 
S 
1 CDCl3 
[0.25] 
HBTM [2.0] 
20 mol% 
54 16 83 70 14 
2 CDCl3 
[0.20] 
HBTM [2.1] 
15 mol% 
49 82 87 93 76 
3 Toluene 
[0.15] 
HBTM [2.1] 
15 mol% 
49 17 87 93 76 
4 Toluene 
[0.20] 
HBTM [2.1] 
8.5 mol% 
54 24 99 86 77 
 
Of the ABCs examined, HBTM-2.1 described by Smith et al.23d displayed the best 
performance and was selected for further optimization (Table 1.1).  The reductive coupling of the 
enantioenriched alcohol (S)-1.82 was carried out using Bolm’s original procedure without 
optimization and delivered a rather low yield of (S,S)-1.78. Having thus obtained sufficient 
quantities of the ligand, we applied Kobayashi’s optimized set of conditions to the Michael 
addition step in our synthesis (Figure 1.14). The reaction with our ketoester 1.63 turned out to be 
even slower than that described by Kobayashi for 1.76. Increasing the concentration of all 
reactants, however, led to lower enantioselectivities. After considerable experimentation, we 
developed an acceptable protocol, which called for elevated temperature and catalyst loading, as 
well as portion-wise addition of MVK. Under these conditions, the reaction was clean and highly 
enantioselective, but stalled after reaching 34% conversion. To improve the overall yield, we found 
that it was most practical to repeat the reaction with recovered unreacted ketoester 1.63, which 
brought the overall yield to 51%.  The absolute stereochemistry of Michael adduct 1.64, however, 
could not be predicted reliably by the transition state model proposed by Kobayashi. Thus, we 
converted it to lingzhiol via our previously developed synthetic scheme and compared its optical 
rotation with that reported by Long and Huang2 in their asymmetric synthesis. The positive sign 
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of rotation indicated that we obtained the opposite enantiomer, with the absolute stereochemistry 
illustrated in Figure 1.23, and thus were able to assign Michael adduct 1.64 as (R). 
 
Figure 1.23: Enantioselective synthesis of (+)-lingzhiol. 
Subsequently, we tried to find alternative methods for the key Michael addition step that 
would produce acceptable enantioselectivities, but require less time. Thus, we turned our attention 
to organocatalysis. Cinchonine 1.86, at 20 mol% catalyst loading, gave 20% conversion in 15 h, 
but the ee was only 23% (Figure 1.24 and Table 1.2, entry 1). It was reported that replacing the 
methyl ester with a bulkier one can greatly increase the enantioselectivity in similar cases.20f 
Indeed, t-butyl ester 1.8724 underwent the Michael addition with much more promising results 
(60% ee). At this point, we decided to optimize the organocatalyst used. Starting with quinidine 
and following Deng’s protocols,25 we prepared catalysts 1.88 and 1.89, which we hoped might 
exhibit better enantioselectivity due to the presence of an additional interaction with the free 
phenolic hydroxyl. Indeed, in the presence of the modified quinidine alkaloid 1.88, the 
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enantioselectivity increased to 83%. Its O-phenanthrenyl analog 1.89, however, was completely 
inactive as a catalyst. Due to time constraints, we had to discontinue further optimization studies 
in this direction. However, available results indicate that, with sufficient time and effort, an 
improved Michael protocol may be found, which will further increase the practicality of our 
synthesis of lingzhiol.  
 
Figure 1.24: Michael addition catalyzed by Cinchona alkaloids. 
Table 1.2: Michael addition promoted by modified Cinchona alkaloids. 
R (mmol) 
CH2Cl2 
[M] 
Catalyst 
(20 mol%) 
Time 
(hr.) 
Conversion 
(%) 
Yield 
(%) 
ee % 
Me (0.03) 0.06 1.86 15 20 - 23 
t-Bu (0.07) 0.06 1.86 45 35 6 60 
t-Bu (0.14) 0.45 1.88 68 42 12 83 
t-Bu (0.11) 0.40 1.89 120 - - - 
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1.4.6 Xie’s synthesis. 
 After we reported our enantioselective synthesis of lingzhiol,4 Xie et al.26 reported a 
synthetic strategy very similar to ours, summarized in Figure 1.25. They also started with tetralone 
1.09 and transformed it into the same glycidol intermediate 1.68 in four steps. They too utilized 
Brønsted acid mediated semipinacol rearrangement, then reductive lactonization to obtain the 
common intermediate 1.16. But, they employed a different strategy for the protection of the alcohol 
group (MOM ether vs. acetate ester) and oxidation at the benzylic position (CrO3 vs. aerial 
oxidation). The MOM group was removed, along with the two methyl ethers, during the 
deprotection with AlCl3 in excess t-BuSH, delivering racemic lingzhiol (±)-1.01.  
 
Figure 1.25: Xie’s synthesis of lingzhiol. 
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1.5 Biological activity of lingzhiol and its analogs. 
 Having developed a practical synthesis of lingzhiol, we were curious if the natural 
product itself or its analogs might also exhibit biological activity in addition to its pSmad inhibitory 
activity described during its isolation.  We noted that the structure of lingzhiol containing a 
butyrolactone derivative with quaternary carbons at α- and β-positions and several hydroxyls, 
bears some resemblance to merrilactone A, which possessed promising activity in promoting 
outgrowth of neurites and thus was considered a potential treatment for neurodegenerative 
diseases, such as Alzheimer’s.27 Professor Yoshiyasu Fukuyama at Tokushima Bunri University 
in Japan, who discovered a number of small-molecule natural products with neurotrophic activity28 
(for example merrilactone A 1.90,28c tricycloillicinone 1.91,28d O-debenzoyltashironin 1.92,28e 
jiadifenin 1.93,28f neocassumunarin A 1.94,28g talaumidin 1.95,28h shown in Figure 1.26), 
graciously agreed to perform a bio-assay on racemic lingzhiol and several of its analogs shown in 
Figure 1.27.  Their results summarized in Table 1.3, showed that, indeed, lingzhiol 1.01 exhibited 
appreciable activity as a promoter of nerve growth factor (NGF) (See experimental section for 
protocol of neurite outgrowth-promoting activity).29 They also noted that lingzhiol exhibited some 
cytotoxicity. Other compounds submitted to Prof. Fukuyama for testing were less active.  The 
bioassay images provided by the Fukuyama group are reproduced below. They illustrate the 
morphology of phenochromocytoma (PC12) cells at 30 µM concentrations of substrates used in 
NGF studies. Under phase-contrast microscope, shown in Figure 1.28, the growth of neurites were 
more pronounced in image ‘c’ than in images ‘b’, ‘d’, ‘e’ and ‘f’. This indicated 1.01 as an active 
promoter of NGF and facilitated the growth of neurons. After obtaining these preliminary results, 
Fukuyama et al. also measured the length of neurite at different concentrations of 1.01 and 
compared them with NGF-treated cells (Figure 1.29). 
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Figure 1.26: Some examples of small molecules with neurotropic effects.   
 
Figure 1.27: Compounds submitted for bio-assay.  
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Table 1.3: Bio-assay result of compounds at different concentrations in DMSO. 
Compounds 30 µM + NGFa 3 µM + NGFa 0.3 µM + NGFa 
1.65 - - - 
syn-1.66 - - - 
anti-1.67 - - - 
1.71 - - - 
1.16 - - - 
1.72 ND ND ND 
1.73 - - - 
1.74 ± - - 
1.75 - - - 
1.01 +++ (cytotoxic) - - 
*B-1 - - - 
*B-2 - - - 
*B-3α ± - - 
*B-3β ± - - 
a1 ng/mL used, +++ : active, ± : weak, - : not active, ND=no data (insoluble) 
*Synthesized by Professor Birman during the model studies on lingzhiol.  
At lower concentrations (0.3 µM and 3.0 µM), the length of neurite was about the same as 
that of NGF nerve cell, but at higher concentration (30 µM), it increased by ca. one-third. Thus, a 
higher concentration of 1.01 was needed for promoting NGF.  For comparison, substrates B-3α 
and B-3β at 30 µM concentration, did not alter the neurite length remained compared with the 
control (NGF-treated neurons, 1st column). 
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Figure 1.28: Phase-contrast microscope images of PC12 after incubation for 4 days with 30 µM 
solution of substrate (a) control experiment (0.001% DMSO), (b) with NGF (1 ng/mL in DMSO), 
(c) with 1.01 + NGF, (d) with 1.74 + NGF (e) with B-3β + NGF and (f) with B-3α+ NGF (Courtesy 
of the Fukuyama group).  
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Figure 1.29: Neurite length measurements of NGF (1 ng/mL) incubated neurons at different 
concentrations of 1.01 (0.3µM, 3.0µM, 30µM), B-3α (30µM) and B-3β (30µM) (Courtesy of the 
Fukuyama group). 
1.6 Future directions 
 Our total synthesis of lingzhiol described in this chapter paves a way to a more detailed 
study of the bioactivity of this unique natural product and its analogues. We believe that our 
synthetic strategy compares favorably with alternative approaches described to date by other 
groups in terms of flexibility and conciseness. It is also more readily amenable to developing an 
enantioselective variant, without adding any steps to the scheme. All these factors bode well for 
30 
 
generating targeted mini-libraries of analogs and testing their activity.  As our preliminary results 
indicate, studies in this direction need not be restricted only to bioassays already reported for 
lingzhiol obtained from nature, but can include other pharmacologically interesting targets. 
Although the neurotrophic activity of lingzhiol proved to be only moderate (it is ca. 30 times 
weaker than merrilactone A 1.90), its simpler structure is more easily amenable to modification, 
and therefore constitutes a promising lead for developing more potent analogs, which, hopefully, 
would be devoid of the unwanted cytotoxicity. The fact that lingzhiol was more active than its 
precursors shown in Figure 1.27, despite their similar molecular weight and gross structural 
resemblance, suggests that our future studies should be directed towards compounds with more 
hydrophilic functional groups in the benzene ring. Studies in this direction are already being 
pursued in our group by Ms. Emma Streff.30 Furthermore, it will be of interest to examine some 
structural variations of the nonaromatic portion of the molecule. For example, as shown in Figure 
1.30, additional substituents on the cyclopentane ring can be easily introduced during the Michael 
addition step. The butyrolactone moiety can be replaced by butyrolactam via reductive amination 
of intermediate aldehyde 1.98.31 
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1.7  Experimental. 
All reagents were commercially available and used as received unless specified 
otherwise. All reactions were carried out under argon, unless noted otherwise. Dichloromethane 
and acetonitrile used as reaction media were freshly distilled from calcium hydride. Solvents used 
for chromatography were ACS or HPLC grade. Reactions were monitored by thin layer 
chromatography (TLC) and 1H NMR. Uniplate HLF (250 μm) silica gel plates were used for TLC. 
Flash column chromatography was performed over Sorbent Technologies silica gel (40-63 
mm). 1H and 13C NMR spectra were recorded on a Mercury 300 MHz and DD2 500 
MHz Agilent spectrometer. The chemical shifts are reported as δ values (ppm) relative to TMS 
using residual CHCl3 peak (7.26 ppm) as the reference. Melting points were measured on a Stuart 
SMP 10 melting point apparatus. High-Resolution mass spectral analyses were performed at 
Washington University MS Center on a Bruker MaXis QTOF mass spectrometer using 
Electrospray Ionization (ESI) method. Infrared spectra were recorded on a Bruker Alpha Platinum-
ATR. HPLC analyses were performed on a Shimadzu LC system using a chiralcel OD-H 
analytical chiral stationary phase column (4.6×250 mm, Chiral Technologies, Inc.) and 
hexane/isopropanol eluent at 1 mL/min flow rate. Signs of optical rotation were determined on a 
Rudolph Autopol III polarimeter.  
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5, 8-Dimethoxytetralone 1.09. Tetralone 1.09 was prepared according to the published 
procedure.9 To a solution of aluminum chloride (0.20 mmol, 26 gm)in nitrobenzene (180 mL), 
dimethoxy benzene 1.59 (0.09 mol, 12.4 g) and succinic anhydride 1.60 were added at 0 °C. The 
solution was allowed to warm up to room temperature. Then, the solution was poured into ice 
water and organic layer was extracted with saturated NaHCO3 solution multiple times. The 
combined aqueous layer was filtered through Buchner funnel and the filtrate acidified to pH 1 with 
concentrated HCl. A light yellow colored precipitate was filtered off and dried to obtain 1.61 in 
50% yield. To a solution of ketobutyric acid 1.61 (0.04 mol, 10.2 g) in diethylene glycol (135 mL) 
containing NaOH (0.28 mmol, 6.52 g), hydrazine monohydrate (0.11 mol, 5.46 g) and water (7.5 
mL) was heated at 100 °C with condenser  for 4 hours to obtain clear yellow solution. Then, the 
solution was heated at 210 °C for 1 hour to obtain brown solution. The solution was cooled to 
about 180 °C and heated at the same temperature for 12 hours. The solution was poured into ice 
cold water containing concentrated HCl and extracted with ether. The combined ethereal layer was 
dried and purified by column chromatography using hexane:ethyl acetate (2:1) as eluent to obtain 
white solid 1.62 in 59% yields. Dimethoxyphenylbutyric acid 1.62 (0.015 mol, 3.40 g) was 
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dissolved in a solution of 85% phosphoric acid (75 gm) and P2O5 (68 gm) at 80 °C and stirred for 
30 minutes. The resulting orange colored solution was poured in ice-water and extracted multiple 
times with ether. The combined ethereal extract was washed with 1M NaOH, brine and water. 
Ether was removed under reduced pressure to obtain pale yellow solid 1.09 in 66% yields (0.01 
mol, 2.06 g). The obtained 1H NMR spectrum of 1.09 matched completely with the reported one.9 
 
 
(±)-Ketoester 1.63. Ketoester 1.63 was prepared according to a published procedure from 
5,8-dimethoxytetralone.10 To a mixture of NaH (34.6 mmol, 832 mg) and CO(OMe)2 (44.8 mmol, 
3.78 mL) in 15 mL THF, a solution of 1.09 (9.45 mmol, 1.89 g) in THF (10 mL)was added 
dropwise over 20 minutes under argon atmosphere. The solution was allowed to reflux for 90 
minutes and allowed to cool to room temperature, a red colored pasty precipitate was observed. 
Glacial acetic acid (2.1 mL) and sufficient amount of water were added to dissolve the precipitate. 
The aqueous solution was extracted with ether multiple times. The combined ethereal extract was 
washed with water, dried and evaporated under reduced pressure to obtain 1.63 in quantitative 
yield.1H NMR spectrum matched completely with the published one.10 
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(±)- Diketoester 1.64. To a solution of 1.63 (529 mg, 2.00 mmol) in 11 mL of CH2Cl2 
under argon and at room temperature, TMG (50 µL, 0.40 mmol) and MVK (416 µL, 5.00 mmol) 
were added and stirred for 16 hours. The reaction mixture was concentrated down to about 1 ml 
and loaded onto a silica gel column and eluted with 3:2 mixture of hexane: ethyl acetate to obtain 
yellow oil (±)-1.64 (531 mg, 1.61 mmol, 79% yield). 1H NMR (300 MHz, CDCl3): δ 6.95 
(d, J=9.4 Hz, 1H), 6.79 (d, J=9.4 Hz, 1H), 3.85 (s, 3H),  3.80 (s, 3H), 3.64 (s, 3H), 2.98-2.67 (m, 
3H), 2.57-2.47 (m, 2H), 2.25-2.15 (m, 1H), 2.14 (s, 3H), 2.11-1.94 (m, 2H). 13C NMR (300 MHz, 
CDCl3): 206.9, 194.0, 171.7, 153.4, 149.5, 132.3, 121.9, 114.6, 109.8, 56.7, 55.7, 55.1, 51.6, 34.4, 
29.6, 29.2, 27.1, 20.0. IR (cm-1): 2936, 2835, 1715, 1683, 1586, 1476, 1349, 1260, 1196, 1068, 
982, 806, 718. MS: HR-ESI calculated for [C18H22O6+H]+: 335.1489, found: 335.1490.  
 
 Asymmetric synthesis of diketoester (R)-1.64. A solution of scandium triflate (18.0 mg, 
0.036 mmol) and Bolm’s ligand (S,S)-1.78 (23.5 mg, 0.072 mmol) in 5.0 mL of 1,2-dichloroethane 
was heated under argon at 60 °C for 1 hour, diluted with an additional 23 mL of 1,2-dichloroethane 
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and heated at the same temperature for another 20 minutes. A solution of ketoester (±)-1.63 (190 
mg, 0.722 mmol) in 5 mL of 1,2-dichloroethane and methyl vinyl ketone (120 µL, 1.440mmol) in 
3 mL of 1,2-dichloroethane were added consecutively to the resulting scandium complex solution. 
The reaction mixture was stirred at 60 °C for 168 hours, then concentrated to ca. 1 mL and loaded 
onto a silica gel column and eluted with hexane/ethyl acetate (5:1→3:1) to afford the unreacted 
starting material (104 mg, 0.393 mmol, 54% recovery) followed by the product, isolated as a 
yellow oil (R)-1.64 (80 mg, 0.242 mmol, 34% yield). The recovered starting material was subjected 
to another cycle following the same protocol as described and yielded an additional amount of (R)-
1.64 (0.130 mmol, 43 mg, 33% yield) and starting material (±)-1.63 (58 mg, 56% recovery). The 
combined yield of the product from two cycles was 51%, or 74% based on recovered starting 
material. HPLC: (5% isopropanol/hexane) [72.3 min (minor); 79.1 min (major)]. [α]D26 = +30.8° 
(c=5.8, CHCl3). The absolute stereochemistry of 1.64, 1.65, 1.66, 1.72, 1.73 and 1.01 were 
assigned by correlation of the optical rotation of the known intermediate (+)-1.16 with previously 
reported data.2 
 
(±)-Tricyclic ketone 1.65. To a cooled room temperature solution of freshly prepared 
sodium methoxide solution from sodium (271 mg, 11.8 mg-atom) and 16 mL of methanol, 
a solution of diketone (±)-1.64 (530 mg, 1.59 mmol) in 9 mL of methanol was  added to it in drop-
wise fashion over 10 minutes with stirring. When the reaction was complete by TLC (13 hours) as 
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indicated by TLC, the mixture was rotary evaporated to dryness, treated with water and extracted 
multiple times with ethylactate. The organic phase was dried over MgSO4, and rotary 
evaporated to obtain the product 1.65 as yellow oil, which crystallized on standing into a pale-
yellow solid.(60 mg, 79% yield). 1H NMR (300 MHz, CDCl3): δ 7.28 (s, 1H), 6.80 and 6.78 
(AB system, J = 9.1 Hz, 2H), 3.81 (s, 3H), 3.78 (s, 3H), 3.61 (s, 3H), 2.92-2.86 (m, 1H), 2.70-2.55 
(m, 1H), 2.50-2.40 (m, 4H), 2.11-2.00 (m, 1H), 1.84-1.73 (m, 1H). 13C NMR (300 MHz, CDCl3): 
200.3, 174.1, 153.4, 151.8, 150.8, 129.0, 128.8, 122.9, 111.6, 109.9, 56.1, 55.1, 52.6, 47.7, 34.5, 
34.5, 34.0, 21.5. IR (cm-1): 2951, 2842, 1725, 2655, 1573, 1465, 1261, 1199, 1071, 802, 732 MS: 
HR-ESI calculated for [C18H20O5+H]+: 317.1384, found: 317.1384. M.pt. 144-147 °C.  [α]D23= 
+274.5° (c = 1.3, CHCl3).  
Following the same protocol as described above, enantioenriched (R)-1.64 (80 mg, 93.5% ee) was 
converted into (R)-1.65 (60 mg, 79% yield). No loss of ee was observed (92% ee). HPLC: (3.3% 
isopropanol/hexane) [52.0 min (minor); 59.3 min (major)]. [α]D23 = +274.5° (c=1.3, CHCl3). 
 
Syn (±)-allylic alcohol 1.66.  To a solution of ketone (±)-1.65 (100mg, 0.316 mmol) in 10 
mL of methanol cooled to -78 °C, CeCl3·7H2O (130 mg, 0.35mmol) was added, followed 
by NaBH4 (60.5 mg, 1.60 mmol). The reaction was slowly allowed to warm up to 0 °C. After 
completion of the reaction, the mixture was rotary evaporated to dryness, treated with water and 
extracted multiple times with ethyl acetate. The organic phase was concentrated down to about 1 
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mL and loaded onto a silica gel column. Elution with hexane/ethyl acetate (1:1) provided the 
minor anti-diastereomer 1.67 (colorless oil, 8.5 mg, 8.7 % yield) followed by the desired syn-
diastereomer 1.66 (white solid, 73 mg, 73% yield).  Data for the anti-isomer 1.67:  1H NMR (600 
MHz, CDCl3): δ 6.88 (s, 1H), 6.74 (d, J =8.8 Hz, 1H), 6.64 (d, J=8.8 Hz, 1H), 4.52 (m, 1H), 3.78 
(s, 3H),  3.75 (s, 3H), 3.51 (s, 3H), 2.83-2.79 (m, 1H), 2.66-2.60 (m, 1H), 2.41-2.38 (m, 1H), 2.12-
2.10 (m, 1H), 1.93-1.87 (m, 2H), 1.85-1.80 (m, 1H), 1.77-1.71 (m, 1H). 13C NMR (600 MHz, 
CDCl3): 176.0, 159.9, 151.4, 134.5, 130.2, 127.0, 126.1, 110.6, 108.7, 66.0, 56.7, 55.8, 52.3, 44.1, 
33.6, 31.2, 28.2, 21.6. IR (cm-1): 3433, 2944, 2833, 1726, 1474, 1261, 1074, 796. MS: HR-ESI 
calculated for [C18H22O5+Na]+: 341.1359, found: 341.1353.  Data for the syn-isomer 1.66: 1H 
NMR (300 MHz, CDCl3): δ 6.90 (s, 1H), 6.76 and 6.65 (AB system, J=9.1 Hz, 2H), 4.34 (broad, 
1H), 3.79 (s, 3H),  3.76 (s, 3H), 3.57 (s, 3H), 2.87-2.79 (m, 1H), 2.65-2.52 (m, 1H), 2.42-2.36 (m, 
1H), 2.30-2.25 (m, 1H), 2.07-2.00 (m, 1H), 1.71-1.60 (m, 4H). 13C NMR (300 MHz, CDCl3): 
176.0, 151.8, 151.2, 132.6, 132.5, 126.5, 125.3, 110.5, 108.25, 68.0, 56.4, 55.5, 52.1, 46.6, 34.1, 
33.5, 28.7, 21.6. IR (cm-1): 3410, 2942, 2867, 1727, 1596, 1474, 1248, 1172, 1136, 1072, 797, 
731. MS: HR-ESI calculated for [C18H22O5+K]+: 357.1099, found: 357.1099. M.pt. 146-148 °C. 
Following the same protocol as described above, enantioenriched (R)-1.65 (57 mg, 93.5% ee) was 
converted into (+)-1.66 (43 mg, 73% yield) without any loss of enantiomeric excess (92.5% ee). 
HPLC: (5% isopropanol/hexane) [19.6 min (minor); 21.6 min (major)]. [α]D23 = +127.5° (c=0.65, 
CHCl3). 
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 (±)-lactone 1.16. To a solution of alcohol 1.66 (51 mg, 0.158 mmol) in 8 mL of 
dichloromethane stirring at 0 °C, m-CPBA (46 mg, 0.24 mmol) was added. After 20 minutes of 
stirring, trifluoroacetic acid (2.4 μL,3.6 mg, 0.031 mmol, 20 mol %) was added, followed, in 30 
seconds by addition of saturated aqueous solution of NaHCO3. After solvent removal, the residue 
was dissolved in 5 mL of methanol, cooled to 0 °C, treated with NaBH4 (33 mg, 0.78 mmol), and 
stirred overnight. The reaction mixture was rotary evaporated to dryness, treated with water 
and extracted with CH2Cl2 (2x5ml). The organic extract was concentrated down and 
chromatographed using hexane/ethyl acetate eluent (3:1→1:1) to obtain (±)-1.16 as white solid 
(27 mg, 56% yield). M.pt. 183-185 °C.1H NMR data for 1.16 matched those reported in the 
literature.2,3 
Following the same protocol, enantioenriched (+)-1.66 (40 mg) was converted into (+)-1.16 (22 
mg, 58% yield, 92.0% ee). HPLC (5% isopropanol/hexane): [46.8 min (minor); 65.4 (major)]. 
[α]D23 = +71° (c=0.20, MeOH).The absolute configuration was assigned by comparison of the sign 
of optical rotation with previously reported data.2  In addition 7.5 mg of anti-aldol 1.71 was isolated 
(18 % yield). 1H NMR (300 MHz, CDCl3): δ 9.62 (s, 1H), 6.81-6.74 (d, J =8.8 Hz, 1H), 6.64 
(d, J=8.8 Hz, 1H), 4.83 (m, 1H), 3.78 (s, 3H),  3.77 (s, 3H), 3.61 (s, 3H), 3.00-2.90 (m, 1H), 2.57-
2.45 (m, 1H), 2.36-2.24 (m, 2H), 2.19-2.10 (m, 1H), 2.06-1.96 (m, 2H), 1.92-1.80 (m, 1H). 13C 
NMR (600 MHz, CDCl3): 206.8, 175.5, 152.0, 150.5, 129.3, 123.6, 109.3, 108.6, 77.6, 65.2, 59.4, 
56.1, 55.8, 52.3, 33.8, 32.0, 29.4, 21.3. IR (cm-1): 3430, 2947, 2842, 1722, 1658, 1474, 1450, 
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1258, 1173, 1069, 796, 729. MS: HR-ESI calculated for [C18H22O6+H]+: 335.1477, found: 
335.1489. 
 
(±)-Acetate 1.72. A solution of (±)-1.16 (27mg, 0.088 mmol) in 1 mL 
of CH2Cl2 stirring at 0 °C was treated successively with acetic anhydride (25.3 µL, 0.27 
mmol), pyridine (21.7 µL, 0.27 mmol) and DMAP (2 mg, 0.018 mmol), allowed to warm to room 
temperature and stirred overnight. The reaction mixture was diluted with CH2Cl2, washed 
with 1M HCl and then water, dried over MgSO4, and rotary evaporated to obtain(±)-1.72 as white 
solid (28 mg, 0.084 mmol, 95% yield). 1H NMR (300 MHz, CDCl3): δ 6.72 and 6.69 
(AB system, J=9.4 Hz, 2H), 5.42 (s, 1H), 4.91 (d, J=10.0 Hz, 1H), 4.09 (J=10.0 Hz, 1H), 3.79 (s, 
3H), 3.77 (s, 3H), 3.13-3.06 (m, 1H), 2.50-2.31 (m, 2H), 2.22-2.18 (m, 1H), 2.12 (s, 3H), 2.04-
1.94 (m, 1H), 1.78-1.60 (m, 3H). 13C NMR (300 MHz, CDCl3): 182.7, 170.4, 151.5, 150.9, 127.3, 
125.8, 109.1, 108.5, 82.8, 72.4, 55.9, 55.6, 55.0, 51.7, 32.9, 31.5, 27.6, 231.5, 18.5. IR (cm-1): 
2939, 2801, 1764, 1737, 1477, 1370, 1232, 1175, 1113, 1086, 1020, 990, 800, 713. MS: HR-ESI 
calculated for [2C19H22O6+Na]+: 715.2725, found: 715.2749. Mpt 178-181 °C.  
Following the same protocol, enantioenriched (+)-1.16 (20 mg) was converted into (+)-1.72 (22 
mg, 96% yield). [α]D26 = +75° (c=0.10, MeOH).  
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(±)-O,O-Dimethyl-lingzhiol acetate 1.73. An oven-dried flask was charged with acetate 
(±)-1.72 (24 mg, 0.072 mmol), N-hydroxyphthalimide (2.3 mg, 0.014 mmol, 20 mol %), AIBN 
(1.2 mg, 0.0072 mmol, 10 mol %), and 1 mL of acetonitrile, equipped with a reflux condenser, 
immersed into an oil bath preheated with 70 °C and kept at that temperature for 24 hours, while 
oxygen was bubbled continuously through the reaction mixture by means of a 
long steel needle. The reaction mixture was allowed to cool to room temperature, loaded directly 
onto a silica gel column and eluted with hexane/ethyl acetate (1:1) to obtain (±)- 1.73 as white 
solid (13 mg, 50% yield). 1H NMR (300 MHz, CDCl3): δ 7.08 (d, J=8.8 Hz, 1H), 6.93 
(d, J=8.8 Hz, 1H), 5.48 (broad, 1H), 4.99 (d, J=10.5 Hz, 1H), 4.49 (d, J=10.5 Hz, 1H), 3.85 (s, 
3H), 3.83 (s, 3H), 2.87 and 2.80 (AB system, J=12.9 Hz, 2H), 2.55-2.44 (m, 1H), 2.13 (s, 3H), 
2.00-1.92 (m, 1H), 1.75-1.64 (m, 2H). 13C NMR (300 MHz, CDCl3): 194.3, 179.6, 170.2, 152.5, 
150.5, 1304, 123.1, 117.2, 112.7, 81.8, 71.3, 56.7, 56.1, 55.4, 53.0, 44.5, 32.0, 31.7, 21.5. IR (cm-
1): 2950, 2817, 1726, 1655, 1574, 1473, 1261, 1071, 1018, 803, 731. MS: HR-ESI calculated for 
[C19H20O7+H]+: 361.1266, found: 361.1282. Mpt 198-201 °C. 
Following the same protocol, enantioenriched (+)-1.72 (19.5 mg) was converted into (+)-1.73 (11 
mg, 51% yield). [α]D25 = +119.3° (c=0.19, MeOH).  
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(±)-O,O-Dimethyl-lingzhiol 1.74. To a solution of 1.73 (13 mg, 0.035 mmol) in3 mL of 
methanol, 1.6mL of 3M aqueous HCl was added. The mixture was refluxed for 15 hours, allowed 
to cool and concentrated down. The evaporation residue was taken up in CH2Cl2, washed with 
water, dried over MgSO4, and rotary evaporated to afford 1.74 as colorless solid (10.5 mg, 0.032 
mmol, 90% yield). M.pt 205-207 °C decomposed. 1H NMR data for 1.74 matched those reported 
in the literature.2,3 
Following the same protocol, enantioenriched (+)-1.73 (8 mg) was converted into (+)-1.74 (6 mg, 
92% yield). [α]D24 = +27.1° (c= 0.42, MeOH).  
 
 (±)-Lingzhiol 1.01. O,O-Dimethyl-lingzhiol 1.74 (10 mg, 0.03 mmol) was treated with 
anhydrous AlCl3 and tert-butylmercaptan according to the procedure of Long and 
Huang2 Racemic lingzhiol (+)- 1.01 was obtained as a yellow solid (5.0mg, 0.017 mmol, 
58% yield). M.pt. 213-215 °C decomposed.  1H NMR data for 1.01 matched those reported in the 
literature.2,3   
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Following the same protocol, enantioenriched (+)-1.74 (3.4 mg) was converted into (+)-1.01 (1.8 
mg, 60% yield, 93.5% ee). HPLC (20% isopropanol/hexane): 9.7 min (minor); 12.7 (major). 
 
(±)-O-Monomethyl-lingzhiol 1.75. To a solution of (±)-1.74 (5.1 mg, 0.016 mmol) in 
CH2Cl2 (1 mL) under argon at -78 °C, BBr3 (47 µL, 0.048 mmol, 1 M solution in CH2Cl2) was 
added. The solution was allowed to reach to room temperature overnight. After quenching the 
solution with water, organic layer was separated, washed with water and dried over MgSO4. The 
solution was rotary evaporated to dryness and loaded onto a silica gel column and eluted with 
hexane: ethyl acetate (2:1) to obtain (±)-1.75 as a yellowish white gel (2.6 mg, 0.009 mmol, 53% 
yield). 1H NMR (300 MHz, CDCl3):δ 11.50 (s, 1H), 7.22 (d, J=9.0 Hz, 1H), 6.92 (d, J=9.0 Hz, 
1H), 5.27 (d, J=9.9 Hz, 1H), 4.32 (m, 1H), 4.28 (d, J=9.9 Hz, 1H), 3.89 (s, 3H), 2.92 and 2.86 
(AB system, J=16.5 Hz, 2H), 2.69 (s, 1H), 2.49-2.41 (m, 1H), 2.01-1.97 (m, 1H),1.78-1.56 (m, 
2H). 13C NMR (500 MHz, CDCl3): 200.6, 179.4, 156.2, 149.3, 131.7, 121.9, 117.6, 115.4, 82.1, 
70.1, 56.9, 53.7, 52.9, 41.2, 33.0, 32.4. IR (cm-1): 3663, 2930, 1760, 1656, 1470, 1285, 1195, 1050, 
856. HR-ESI calculated for [C16H16O6+Na]+: 327.0839, found: 327.0823. Mpt 200-202 °C 
decomposed. 
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(±)-Diketo t-butylester 1.90.  Ketoester 1.87 was prepared according to the published 
procedure.24 To a solution of 1.87 (15.8 mg, 0.052 mmol) in CH2Cl2 (0.3 mL) under argon, TMG 
(1.3 µL, 0.01 mmol) and MVK (11 µL, 0.133 mmol) was added and allowed to react for 24 hours. 
After completion of reaction, the solution was directly loaded onto a silica gel column and eluted 
with hexane/ethyl acetate (3:1) to obtain (±)- 1.90 as white solid (8 mg, 0.02 mmol, 41% yield). 
1H NMR (300 MHz, CDCl3): δ  6.92 (d, J=9.0 Hz, 1H), 6.77 (d, J=9.0 Hz, 1H), 3.84 (s, 3H), 3.79 
(s, 3H), 2.90-2.74 (m, 3H), 2.55-2.42 (m, 2H), 2.20-2.10 (m, 4H), 2.04-1.89 (m, 2H), 1.27 (s, 9H). 
13C NMR (500 MHz, CDCl3): 208.4, 195.7, 171.2, 153.8, 150.4, 133.0, 124.2, 114.7, 110.2, 82.1, 
57.9, 56.7, 56.1, 39.5, 31.2, 30.1, 28.2, 28.0, 21.0. IR (cm-1): 2973, 2936, 2836, 1717, 1695, 1589, 
1477, 1434, 1368, 1262, 1156, 1093, 1067, 979. MS: HR-ESI calculated for [2(C21H28O6)+Na]+: 
775.3664, found: 775.3659. Mpt 132-134°C. 
Following the same protocol, tert-butyl ketoester 1.87 (41.4 mg, 0.135 mmol) was dissolved in 
CH2Cl2 (0.3 mL) under argon, to which catalyst 1.88 (5.2 mg, 0.013 mmol) and MVK (23 µL, 0.27 
mmol) were added and stirred at room temperature for 24 hours. The incomplete reaction was 
directly loaded onto a silica gel column, eluted with hexane/ethylacetate (3:1) and separated 
product (+)-1.90 (6 mg, 0.016 mmol 12% yield, 83% ee) from starting material 1.87 (22.6 mg, 
0.074 mmol). HPLC (2.5% isopropanol/hexane): 68.4 min (minor); 83.0 (major)]. [α]D22 = + 61.3° 
(c= 0.62, CHCl3).  
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Protocol of neurite outgrowth-promoting activity:29 (procedure provided by Prof. 
Fukuyama, Tokushima Bunri University,  Japan). Phenochromocytoma  (PC12) cells were 
cultured in a 24-well plate at density of 8 × 103 cells/mL in DMEM + 10% HS, 5% FBS, 100 
IU/mL penicillin, and 100 μg/mL streptomycin at 37 ˚C under a humidified atmosphere of 95% 
air and 5% CO2 for 24h. The culture medium was then changed to DMEM + 2% HS, 1% FBS, 
100 IU/mL penicillin, and 100mg/mL streptomycin. At the same time, different concentrations of 
test samples with 1 ng/mL NGF were added. One concentration experiment was repeated in three 
wells. After incubation with samples for 4 days, the cultures were fixed with 4% 
paraformaldehyde/ PBS and stained with methylene blue. Cell morphology was observed under a 
phase-contrast microscope, and neurite length was quantified. Ten images were selected randomly 
under a microscope for each well, and five significantly differentiated cells were selected to 
measure the longest neurite length extending from a cell body for each picture. At least 70 cells 
were calculated for each concentration. Statistical analyses were performed using Dunnet’s t test. 
** P<0.01versus NGF. 
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Chapter 2: Axially Chiral NHC Catalysts 
2.1 Introduction. 
 N-Heterocyclic carbenes (NHCs) are widely used in catalysis both as organocatalysts and 
as ligands for metal ions. Among them, NHCs shown in Figure 2.1, which are derived from 5-
membered heterocyclic cations—thiazolium, triazolium, imidazolium and imidazolinium—are 
especially common.  
 
Figure 2.1: Common types of NHCs. 
 
Figure 2.2: Chiral NHCs with α-stereogenic carbon substituents. 
Their asymmetric versions are most commonly designed by attaching a stereogenic carbon 
directly to one or two of the nitrogen atoms, in the form of either an unrestrained secondary 
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substituent (2.05-2.07)1 or an additional ring (2.08-2.10) (Figure 2.2).2 Needless to say, this type 
of catalyst geometry is often highly effective in inducing enantioselectivity:  otherwise, it would 
not have gained so much popularity. However, it is by no means universal. This is why alternative 
types of chiraphores are needed: to be able to create a geometrically different asymmetric 
environment and thus achieve high asymmetric induction when the catalysts with alpha-
stereogenic centers fail to do so. Achiral NHCs with N-aryl groups, especially those with bulky 
ortho-substituted aryls (e.g., 2.01-2.04, R1 = 2,4,6-trimethylphenyl or 2,6-diisopropylphenyl), are 
widely employed in catalysis because the aryl substituents create a “bowl” around the reactive 
site.3 Rendering N-aryl-NHCs chiral presents unique opportunities in catalyst design, because the 
resulting geometry would be difficult to reproduce with the alpha-stereogenic substituents 
discussed above.   
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Figure 2.3: Chiral NHCs incorporating chiral N-aryl substituents. 
Several strategies can be employed to reach this objective. One is to render the aryl groups 
themselves chiral (Figure 2.3). For example, Andrus et al. utilized the planar chirality of 
paracyclophane to design C2-symmetrical ligand 2.11.4 Hoveyda et al. prepared unsymmetrical 
ligand 2.12 with an axially chiral biaryl substituent.5 Gawley et al.6 recently synthesized 
imidazolylidene carbene 2.13. Its Cu (I) complex produced excellent enantioselectivity in 
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hydrosilylation of ketones. The “redundant” chiral α-phenethyl groups used in this design ensure 
that either face of the N-aryl will project the same substituents—the phenyl and the methyl—
towards the reactive site. The analogous Cu (I) complex of 2.14 bearing one chiral ortho-
substituent on each N-aryl group was only moderately enantioselective in hydrosilylation of 
acetophenone. 
An alternative approach is to use achiral N-aryl groups to transmit chirality from 
stereogenic centers on the backbone of the heterocyclic core to the nucleophilic carbon. This 
approach proved especially effective in designing imidazolinylidene carbene ligands, e.g., 2.15-
2.17 (Figure 2.4).7  In a conceptually similar fashion, Bach et al.8 prepared thiazolylidene carbene 
2.18, in which the orientation of the N-aryl group was expected to be controlled by the stereogenic 
center attached to the backbone. Carbene 2.18 was found to catalyze benzoin condensation9 of 
benzaldehyde with 40% ee. This modest result was attributed to the configurational mobility of 
the mono-ortho-substituted N-aryl group.  
  
Figure 2.4: Chiral NHCs with achiral N-aryl substituents. 
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2.2.  New catalyst design. 
In contrast to the chiral N-aryl-NHC designs presented in Figure 4.4 above, which 
effectively rely on the induced chirality of the C—N axis, one can envision a design in which 
rotation about the C—N axis is restricted kinetically, thus rendering the two enantiomers thermally 
stable atropisomers.  An attempt to exploit this concept was made by Bach et al.8 when they 
synthesized atropisomerically stable anti-imidazoline-2-thione 2.19 and converted it into the 
corresponding imidazolium cation 2.20 (Figure 2.5). Unfortunately, the latter turned out to be 
configurationally unstable and, somewhat surprisingly, existed preferentially in the syn-form 
(meso-2.20). 
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Figure 2.5: Configurationally unstable atropisomers. 
 In hindsight, the configurational mobility of 2.20 could have been anticipated, because 
axially chiral biaryls usually require at least three non-hydrogen substituents around the 
stereogenic axis to be sufficiently thermally stable. In the case of N-aryl-NHCs, this would mean 
having two different o-substituents on the N-aryl group and one on the heterocyclic backbone 
(Figure 2.6).  The resulting NHC design, which would depend solely on the stable stereogenic C—
N axis for its chirality, would be a promising addition to the arsenal of available asymmetric 
catalysts and ligands, provided that its enantiomers could be prepared in pure form by asymmetric 
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synthesis or resolution of racemates. Optionally, additional stereocenters could be introduced at 
one of the o-substituents for synthetic convenience for ease of separation. 
`  
Figure 2.6: Schematic representation of the new catalyst design.  
 
Figure 2.7: Performance of chiral thiazolylidenes in asymmetric benzoin condensation. 
 Potential ramifications of the axially chiral NHC design concept described above could be 
significant. Usually, the design of chiral NHC organocatalysts is based on blocking one of the 
faces of the reactive heterocyclic core, i.e. on repulsive interactions. The presence of two different 
substituents, R1 and R2, would allow us to introduce both a sterically demanding group on one face 
and a hydrogen bond donor or acceptor on the other, thus taking advantage of attractive interactions 
as well. In short term, however, we simply wanted to demonstrate the feasibility of the new 
concept. To do so, we decided to focus on preparing an axially chiral thiazolylidene and testing its 
enantioselectivity in asymmetric benzoin condensation. It should be noted that, although chiral 
55 
 
thiazolylidenes were the first NHCs to be explored in this transformation (and asymmetric 
organocatalysis in general), they never reached useful levels of enantioselectivity (Figure 2.7). 8,10 
2.2.1  Proof of principle study 
 Our first objective was to demonstrate that trisubstituted N-aryl-thiazolium cations are 
indeed configurationally stable at temperatures required for their preparation and use in catalysis. 
To this end, we first prepared racemic o,o′-disubstituted chiral aniline 2.27 from 2.26 via a known 
procedure (Figure 2.8).  
 
Figure 2.8: Synthesis of atropisomeric thiazolium cations. 
Its transformation into N-aryl-thiazoline-2-thione yielded two chromatographically 
separable diastereomers in ca. 1:1 ratio. Their relative stereochemistry was tentatively assigned by 
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comparing the chemical shifts of protons on the heterocyclic backbone: the fact that the both the 
C5 vinylic proton and especially the C4-methyl of 2.28b were shifted significantly up field 
suggested that they were shielded by the phenyl group of the α-phenethyl substituent (Figure 2.9). 
 Oxidation of these thiones with hydrogen peroxide in acetic acid yielded the corresponding 
diastereomeric thiazolium cations, which did not interconvert on heating in refluxing acetic acid 
for 3.5 hours, which suggested that two substituents not larger than methyl group were sufficient 
to restrict the rotation about the C—N axis. Again, observation of the chemical shifts in 1H NMR 
was fully consistent with the originally assigned stereochemistry: the C2-proton of 2.29a clearly 
experienced the shielding effect of the phenyl group (Figure 2.9).  
 
Figure 2.9: Tentative assignment of diastereomeric series by 1H NMR. 
 Having thus confirmed the key premise of our catalyst design, we proceeded to the next 
step of our study: making atropisomeric NHCs 2.29a and b in enantiopure form.  Although 
enantiopure aniline 2.27a could in principle be obtained via semipreparative chiral stationary phase 
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HPLC separation or a different two-step asymmetric route, we opted to develop a classical 
resolution procedure for its racemate. After considerable experimentation, we found that its 1:1 
salt with dibenzoyltartaric acid (DBTA) could be crystallized from diethyl ether-benzene with 
significant enrichment (88-96% ee of recovered aniline base after a single recrystallization). 
Assignment of the absolute stereochemistry of individual enantiomers of 2.27a, however, was 
difficult, because both diastereomeric DBTA salts failed to produce X-ray quality crystals. 
Moreover, whereas racemic aniline 2.27a crystallized easily in large clear crystals, its individual 
enantiomers were oils. Fortunately, thiazoline-2-thione (-)-2.28a obtained from (+)-2.27a 
(recovered from the less soluble diastereomeric salt with D-DBTA) was a nicely crystalline solid. 
Its X-ray structure obtained by Ms. Emily Reeves (Mirica group) two years after completion of 
these studies, allowed its absolute configuration to be assigned as (Ra,R) based on the Flack 
parameters11 (Figure 2.10).  
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Figure 2.10: ORTEP crystal structure of (Ra,R)-2.28a. Displacement ellipsoids are drawn at the 
50% probability level.  
 Enantio-and diastereomerically pure (>98%) thiazoline-2-thiones (Sa,S)-2.28a and (Ra,S)-
2.28b obtained from the classical resolution of 2.27a with L-DBTA were converted into the 
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corresponding thiazolium salts (Ra,S)-2.28a and (Sa,S)-2.28b, respectively, via the protocol shown 
above in Figure 2.8 (note the reversal of Sa and Ra descriptors of axial stereochemistry). The stage 
was set for testing their performance in asymmetric benzoin condensation. Thiazolylidene carbene 
(Ra,S)-2.30a derived from the (Sa,S)-2.28a was predicted to be the more enantioselective of the 
two, because it would produce Breslow intermediate (Sa,S)-2.31a in which one of the faces of the 
nucleophilic carbon would be blocked by the phenyl group rather than the methyl (cf. (Ra,S)-2.31b) 
(Figure 2.11). 
 
Figure 2.11:  Predicted orientations of diastereomeric Breslow’s intermediates  
 Indeed, benzoin condensation in THF in the presence of triethylamine catalyzed by the 
crude (Ra,S)-2.29a led to (S)-benzoin12 in ca. 60% ee, shown in Figure 2.12. Modest improvement 
(66-70% ee) was observed when the reaction was carried out in tert-butanol. Although the 
enantioselectivity was only modest, it was the highest ever obtained in this reaction with 
thiazolylidene carbenes (cf. Figure 2.7). As expected, the diastereomeric catalyst (Sa,S)-2.29b gave 
the opposite enantiomer of benzoin with lower enantioselectivity (ca. 30% ee).  
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Figure 2.12: Benzoin condensation catalyzed by (Ra,S)-2.29a.  
2.2.2 Optimization of the catalyst design  
 Having demonstrated that our new catalyst design shows promise in benzoin condensation, 
we sought to optimize it further to achieve more respectable ees. We 
reasoned that, if the Breslow intermediate generated from our axially 
chiral thiazolylidenes can be depicted by the general structure 2.34, then 
the asymmetric induction would be influenced primarily by (a) the aryl 
group blocking the bottom face of the nucleophilic carbon and (b) by the 
R2 group positioned on the top face, where it might interact directly with the incoming electrophile.  
In our proof-of-principle example 2.31a, the aryl group was represented by an unsubstituted 
phenyl. We speculated that increasing its size and/or π-stacking ability (i.e., variation of R4) might 
improve the overall performance. It would be interesting to replace the methyl group currently 
occupying the R2 position with something functional, such as a hydrogen bond donor or acceptor. 
However, developing the synthesis of requisite precursors would require considerable time. 
Therefore, for the time being, we limited our study to compounds obtainable via our established 
synthetic scheme with minor modifications.  
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 Preparation of optically enriched anilines. Racemic 2-(2arylethyl)anilines were obtained 
via a microwave-assisted modification of the Coates’ protocol, as described in the next chapter of 
this thesis.  Their classical resolution with L-dibenzoyltartaric acid (L-DBTA) was generally 
successful, although still required some experimentation to find the optimal solvent and 
crystallization conditions. In a typical procedure, racemic o-substituted chiral anilines 2.27 (1 
equivalent) and, L-DBTA 2.35, 1 equivalent) were dissolved after gently heating in a minimum 
amount of diethyl ether.  To this solution, an appropriate solvent such as toluene, benzene or 
hexane, was added and the ether was removed by concentration on a rotary evaporator. On cooling 
to room temperature, the solution sometimes congealed into a thick gel and had to be gently re-
heated and cooled again to ensure that the fine white precipitate could be separated by filtration. 
Multiple recrystallizations were sometimes necessary to obtain high optical purity. Results of 
successful resolutions are summarized in Table 2.1.   
Table 2.1: Chiral anilines resolved with L-DBTA 
 
Entry R Ar Solvent % recovery Final % ee* 
1 Me Ph PhH 68 99 
2 Me 4-t-BuC6H4 Toluene 36 97 
3 Me 1-Naphthyl Toluene 55 99 
4 Me 2-Naphthyl Toluene 22 98 
5 H Ph Toluene 39 94 
*The absolute configurations shown was assigned by analogy with (Ra,R)-2.28a. 
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 In addition to enantioenriched anilines shown above, we prepared brominated derivative 
2.27'e starting with resolved aniline 2.27e (Figure 2.13).  
 
Figure 2.13: Bromination of aniline 2.27e.  
Table 2.2: Preparation of atropisomeric thiazoline-2-thiones. 
 
Entry R Ar Cyclization (Sa,S)/(Ra,S)  
(% total yield) 
(Sa,S)  
(% ee) 
(Ra,S)  
(% ee) 
1 Me Ph HCl, EtOH, Δ 1:1 (54%) 98 99 
2 Me 4-t-BuC6H4 HCl, EtOH, Δ 1:1 (44%) 99 99 
3 Me 1-Naphthyl AcOH, rt 1:1 (69%) 97 99 
4 Me 2-Naphthyl HCl, EtOH, Δ 1:1 (20%) 99 98 
5 Br Ph HCl, EtOH, Δ 1.5:1 (6%) 99 87 
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 Preparation of atropisomeric thiazoline-2-thiones. Enantiopure anilines 2.27 were 
converted into the corresponding thiazoline-2-thiones 2.28, following the literature protocol8 used 
above to prepare 2.28. The key acid-catalyzed cyclization step (cf. 2.36→2.28, Table 2.2) generally 
led to approximately 1:1 mixtures of diastereomers, which were separated by flash 
chromatography. The undesired diastereomer was always eluted first, followed by the desired one. 
In the case of 2.28c (1-naphthyl), the standard cyclization protocol involving heating with aqueous 
HCl in EtOH gave predominantly the undesired diastereomer. Fortunately, when the reaction was 
carried out at room temperature in neat acetic acid overnight, ca. 1:1 ratio was obtained. 
Enantiopurity of all thiones was established by HPLC. 
 Preparation of thiazolium salts and their application in benzoin condensation. The 
desired (Sa,S) diastereomers of enantioenriched thiones 2.28a-2.28e were converted into the 
corresponding (Ra,S) thiazolium salts via oxidation with H2O2 in acetic acid followed by solvent 
removal by co-evaporation with toluene. The resulting crude thiazolium hydrosulfates were tested 
for enantioselectivity in benzoin condensation. The results are summarized in Table 2.3. The 
original catalyst 2.29a, as well as its t-butylphenyl analog 2.29b provided the best 
enantioselectivity (Table 2.3, entries 1 and 2), the latter being somewhat more active. The 1-
naphthyl analog 2.29c exhibited only poor reactivity (Table 2.3, entry 3). Unfortunately, the 2-
naphthyl group in 2.29d, which we had hoped would be superior to phenyl due to its improved π-
stacking properties, actually gave lower enantioselectivity, albeit higher reaction rate (entry 4). 
Finally, replacing the ortho-methyl group with bromine (cf. 2.29e) led to the lowest 
enantioselectivity and the highest reaction rate (entry 5). The latter observation—that the most 
electron-deficient and therefore most acidic thiazolium salt appears to function as the most active 
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catalyst—suggested that overall rate for other catalysts may be limited by the incomplete 
deprotonation with triethylamine.  
 Table 2.3: Screening of catalyst. 
 
Entry Catalyst (mol %) % conversion % ee % Yield 
1 2.29a (20) 56 62 - 
2 2.29b (20) 69 61 80 
3 2.29c (20) 15 50 - 
4 2.29d (14) 99 43 54 
5 2.29e (8) 97 27 88 
 
 Before proceeding to screen various bases, we converted catalyst 2.29a from its 
hydrosulfate form to perchlorate. This resulted in a noticeable improvement of enantioselectivity 
(62% to 70% ee, cf. entry 1, Table 2.3 vs. entry 1, Table 2.4). Surprisingly, other tertiary amine 
bases, such as Hunig’s base, DABCO and Proton Sponge were completely ineffective (Table 2.4, 
entries 2-4). On the other hand, DBU turned out to be superior to triethylamine in terms of reaction 
rate and gave another modest improvement of enantioselectivity (Table 2.4, entry 5). The reaction 
proceeded even faster in EtOH, but with lower ee (Table 2.4, entry 6). These results were consistent 
with our expectation that more complete deprotonation of the NHC precursor would accelerate the 
reaction. However, a closely related amidine base, DBN, and the stronger guanidine base TBD 
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were much less effective (Table 2.4, entries 7 and 8). Ionic bases were examined next. Potassium 
t-butoxide resulted in a faster reaction, but very low ee (Table 2.4, entry 9), while other, weaker 
bases, were slower than triethylamine (Table 2.4, entries 10-12). 
Table 2.4: Screening of bases 
 
*100% ethanol was used as solvent. 
Entry Base (10 mol%) Time (hr) Conversion (%) ee (%) Yield (%) 
1 NEt3 18 73 70 56 
2 DIPEA 24 traces - - 
3 DABCO 21 traces - - 
4 Proton sponge 24 traces - - 
5 DBU 3 98 74 56 
6* DBU 1 98 51 91 
7 DBN 3 21 56 - 
8 TBD 3 38 56 - 
9 t-BuOK 1.5 94 14 - 
10 N(C4H9)4F 21 62 56 52 
11 Cs2CO3 46 traces - - 
12 PhCOOCs 24 - - - 
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Table 2.5: Screening of additives. 
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Entry Additive (mol %) mol % DBU time, h % conv % ee % yield 
1a none 10 2 96 20 - 
2 PhCO2H (10)  20 2.5 100 63 67 
3 PhCO2H (10)  22.5 4.5 84 64 51 
4 PhCO2H (15) 22.5 4 100 31 50 
5 9-anthrylCO2H (10) 20 1.5 90 9 50 
6 3,5-(HO)2PhCO2H (10)  20 4 94 57 - 
7 catechol (10) 20 3.5 59 26 - 
8 CeCl3 (10) 20 48 - - - 
9 Ti(OPr)4 (10) 20 3 49 52 - 
 
At this point, we deliberated on the direction of further optimization studies that would allow us 
to reach the coveted 90% ee barrier, and decided to purify all solvents, bases, and benzaldehyde 
by distillation and carry out the reaction under inert atmosphere. All of a sudden, we could no 
longer reproduce even the 60-70% ees obtained in previous experiments that we began to take for 
granted.  After reading the literature, we realized that the poor results may be due to the absence 
of benzoic acid in the freshly distilled benzaldehyde. Its function as a “secret” co-catalyst may be 
in facilitating proton transfer between the Breslow intermediate and benzaldehyde in the transition 
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state. Indeed, the sample of benzaldehyde we had used up to this point in our test reactions 
contained 10 % benzoic acid by NMR. Upon addition of 10 mol% of benzoic acid to our reaction 
with purified benzaldehyde, we managed to partially restore the original enantioselectivity (Table 
2.5, entries 1 vs 2). Varying the amounts of benzoic acid and DBU was detrimental (Table 2.5, 
entries 3 and 4). Other additives tested, including different carboxylic acids (Table 2.5, entries 5 
and 6), catechol (Table 2.5, entry 7) and Lewis acids (Table 2.5, entries 8 and 9) were also 
ineffective or detrimental. 
2.3 Conclusions and future directions. 
 Our results obtained thus far indicate that the axially chiral N-aryl-NHC ligand design has 
the potential to provide a valuable alternative to existing designs. Indeed, our 2.29 catalysts, while 
still far from perfect, outperformed all other chiral thiazolylidenes described to date (2.18, 2.23-
2.25) in asymmetric benzoin condensation. Intriguingly, the absolute sense of asymmetric 
induction observed with 2.29 is the opposite of that of 2.18, 2.23-2.25, even though the same Re 
face of Breslow’s intermediate is presumed to be blocked in all these cases.  We still do not have 
an explanation for this apparent reversal of enantioselectivity. However, the fact that co-catalysis 
with benzoic acid appears to be critical for our catalysts indicates that the transition state is likely 
to be more complex than one might assume. Perhaps the first step in continuing research in this 
direction should be to test a wider variety of asymmetric reactions than just the prototypical 
benzoin condensation we chose for our initial study.   
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In addition, the preparation of enantio- and diastereomerically pure axially chiral NHCs 
still presents a considerable hurdle, which explains in part why we have been able to examine only 
a narrow range of structural variations of our catalyst design. While the use of an auxiliary chiral 
center of 1-arylethyl groups has allowed us to separate and explore the first examples of axially 
chiral NHCs, we do not expect it to be practical in the long run. In the future, it will be worthwhile 
to explore chiral NHCs having only the stereogenic C—N axis in their structures, exemplified by 
structure 2.37. The use of semipreparative chiral stationary phase HPLC may provide a practical 
means of resolving racemic axially chiral NHC precursors and thus 
facilitate a broader study of structural variations of our catalyst design. 
Later, if promising catalysts are identified, more scalable procedures may 
be found for their preparation in enantiopure form, e.g., via the classical 
resolution of racemic thiazolium cations.  
 Among structural variations of our catalyst design that would be especially interesting to 
explore, we can mention (a) a wider range of Ar groups, including electron-withdrawing ones, (b) 
a functional ortho-substituent R, instead of the methyl group, (c) replacing the thiazolium core 
with triazolium or imidazolium, which possess a different reactivity profile and therefore would 
allow us to explore the application of axially chiral NHCs to a wider range of asymmetric 
organocatalytic transformations and (d) using axially chiral NHCs as ligands for metal cations, 
which would open a whole new direction in their application to asymmetric catalysis. 
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2.4 Experimental. 
 All reagents were obtained commercially and used as received, unless specified otherwise. 
Solvents used for chromatography were ACS grade. Reactions were monitored by thin layer 
chromatography (TLC) and by 1H NMR. Uniplate silica gel 250 HLF plates were used for TLC 
analyses. Flash column chromatography was performed over Sorbtech silica gel (40-63mm). 1H 
NMR and 13C NMR spectra were recorded on a Mercury 300 MHz Varian Spectrometer. The 
chemical shifts are reported as δ (ppm) relative to TMS using residual CHCl3 peak (7.26 ppm) as 
the reference. High- Resolution mass spectral analyses were performed at Washington University 
MS Center on a Kratos MS-50TA spectrometer using Electrospray Ionization (ESI) method. 
Infrared spectra were recorded on a Perkin-Elmer Spectrum Bx FTIR spectrophotometer using 
potassium bromide plates or on a Bruker Alpha Platinum-ATR. Melting points were measured on 
a Stuart SMP 10 melting point apparatus.  HPLC analyses were performed on a Shimadzu LC 
system using a Chiralcel OD-H and AD-H analytical chiral stationary phase column (4.6×250 mm, 
Chiral Technologies, Inc.) and hexane/isopropanol eluent at 1 mL/min flow rate. Signs of optical 
rotation were determined on a Rudolph Autopol III polarimeter.  
2.4.1 Classical resolution of o-chiral substituted racemic anilines 
 2.27a. To a solution of (±)-2.27a (3.38 gm, 15 mmol) in Et2O (25 mL), L-DBTA (5.38 
gm, 15 mmol) was added in small portions. Not all the solid dissolved, and a solid suspension was 
observed. Benzene (10 mL) was added to the reaction mixture and then evaporated under reduced 
pressure to remove Et2O. Again, benzene was added (60 mL) and heated to reflux with a magnetic 
stirrer. The partially dissolved solid was stirred and allowed to cool to room temperature. After 1.5 
hours, the precipitate was filtered off and rinsed with benzene (15 mL). A small sample from the 
1st precipitate was dissolved in ether and treated with base (2M NaOH). The organic fragment was 
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washed with brine solution, dried over MgSO4, evaporated under reduced pressure, and analyzed 
by HPLC to obtain 88% ee. The filtrate contained about 64% ee. This first precipitate was 
transferred back to the flask and toluene (75 mL) was added and heated to reflux. White suspension 
was observed as not all solids were dissolved. The solution was left stirring overnight. The next 
day, the precipitate was filtered off and rinsed with benzene (10 mL). The filtrate from the 1st crop 
remained unchanged with no sign of gelation.  A small sample from this dried 2nd crop was 
analyzed by chiral HPLC.  96% ee was observed. The 2nd crop was suspended in benzene (50 mL) 
and heated to reflux. The suspension was left stirring overnight at room temperature. The next day, 
the suspension was filtered off and rinsed with benzene (10 mL). After drying, 3.0 g precipitate 
were obtained. The ee was found to be 99%. Overall, 68% salt was recovered. [α]D25 = -63.8° (c= 
0.104, CHCl3). When the same process was repeated for the classical resolution of racemic 2.27a 
with D-DBTA, it provided the enantiomer with the opposite optical rotation. [α]D23 = +60.8° (c= 
0.356, CHCl3).  
 2.27b. To a solution of (±)-2.27b (3.53 gm, 12.5 mmol) in Et2O (30 mL), L-DBTA (4.72 
gm, 12.5 mmol) was added in small portions. After dissolving all solids, a clear yellow solution 
was observed. Toluene (10 mL) was added to the reaction mixture and evaporated under reduced 
pressure to remove Et2O. Again, toluene was added (20 mL) and the solution was heated to reflux 
with a magnetic stirrer. The net weight of the salt was 28 g. The solution was stirred over a warm 
stir plate at ca. 40 °C. A thick gelatinous suspension was observed. Further heating of the gel 
turned into liquid and allowed to cool with stirring. The solution was left for two days on a warm 
plate. A very fine white precipitate was observed. The precipitate was filtered through size-D 
sintered glass funnel and washed with toluene (12 mL). The 1st crop was obtained in about 4 g 
with 73% ee. During filtration, filtrate began to congeal as the temperature dropped below room 
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temperature. The filtrate was dried under reduced pressure and stored in a separate vial. The 1st 
crop was dissolved in toluene (6 mL) and heated to reflux. The solution was concentrated to about 
8 g by boiling off any excess toluene and then left to crystallize while stirring on a warm plate.  
After 4 hours, extremely thick suspension of microcrystal was observed. The crystals were filtered 
and rinsed twice with toluene (4 mL). Usual workup provided 85% ee.  The solid from 2nd crop 
was dissolved in minimal amount of toluene (4 mL) and left to crystallize. After 4 hours, the 
microcrystals were filtered, rinsed with toluene. 1.5 g white powder was obtained and 97% ee was 
measured. Overall 36% salt was recovered. [α]D23 = -42.1° (c= 0.342, CHCl3).  
 2.27c. To a solution of (±)-2.27c (1.7 g, 6 mmol) in Et2O (10 mL), L-DBTA (2.26 g, 6 
mmol) was added. Amine didn’t dissolve completely, then toluene (10 mL) was added to the 
solution and heated to reflux. After dissolving all solids, a clear yellow solution was observed. 
This solution was stirred and allowed to cool to room temperature. A white precipitate was 
observed and filtered. The solid residue was washed with toluene (5 mL). About 1.7 g white solid 
was obtained with 80% ee. The 1st crop was suspended in Et2O (15mL), and toluene (5 mL) was 
added to it. The solution was heated to reflux. A clear colorless solution was observed and left 
overnight while stirring at room temperature. The next day, a precipitate was observed, which was 
filtered and washed with toluene (5 mL).  About 1.1 g of white solid was collected, and 99% ee 
was measured. Overall 55% of the salt was recovered. [α]D25 = -78.5° (c= 0.179, CHCl3).  
 2.27d. To a solution of (±)-2.27d (3.61 g, 13.1 mmol) in toluene (50 mL), L-DBTA (4.95 
g, 13.1 mmol) was added. The solution was heated to reflux. A clear yellow color solution was 
observed which was left overnight at room temperature without stirring. The next day, a white 
precipitate was observed and filtered to obtain 7.2 g salt. The ee of the 1st crop was determined to 
be 46%. This 1st crop was dissolved in toluene (50 mL) and allowed to cool to room temperature. 
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White precipitate was observed and filtered to obtain 2.28 g. Its ee was determined to be 89%. The 
2nd precipitate was dissolved in minimum amount of Et2O, and toluene (15 mL) was added. The 
solution was heated to reflux until all ether was evaporated and then allowed to cool to room 
temperature. A white precipitate was observed, which was filtered and collected to obtain 1.2 g of 
solid. The ee of the 3rd crop was determined at 95.5%. The third crop was partially dissolved in 
Et2O, and toluene (7mL) was added to the solution and heated to reflux. Once all the ether was 
evaporated, the solution was allowed to cool to room temperature. A white precipitate was 
observed. The precipitate was filtered to obtain 0.940 g of product. The ee was measured to be 
98%.  Overall, 22% of the salt was recovered. [α]D22 = -63.0° (c= 0.437, CHCl3).  
 2.27e. To a solution of (±)-2.27e (13.36 g, 63.65 mmol) in toluene (250 mL), L-DBTA 
(21.52 gm, 63.65 mmol) was added. The solution was heated to reflux. A yellowish-white 
suspension was observed. After decanting, the 1st crop was filtered, and its ee was determined, and 
found to be 30%. The first crop was heated to reflux in toluene (250 mL) and allowed to settle to 
obtain a top clear yellow solution and a bottom white precipitate. The 2nd crop provided 61% ee. 
It was again partially dissolved in toluene (240 mL), decanted and filtered to obtain the 3rd crop in 
11.5 g as a white residue with 77% ee.  Partial dissolution of 3rd crop in toluene (175 mL) provided 
the 4th crop as a white solid in 86% ee.  The 4th crop was again partially dissolved in toluene 
(85mL) to obtain the 5th crop in 88% ee. Following the above procedure, partial dissolution in 
toluene (30 mL each), and the 5th crop yielded the 6th crop in 89% ee, which in turn yielded the 7th 
crop in 91% ee. After the 8th, 9th and 10th crop from partial dissolution in toluene (30 mL each), 
6.85 g salt was obtained. HPLC analysis revealed that the ee was 94%.  Overall, 39% of the salt 
was recovered. [α]D25 = -78.8° (c= 0.065, CHCl3).  
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 Bromination of aniline 2.27'e. To a solution of (-)-2.27e (422 mg, 2.0 mmol) in CH2Cl2 
(4 mL) in an ice-water bath, NBS (355 mg, 2 mmol) was added portion-wise. This solution was 
allowed to stir for 30 minutes. The ice-water bath was removed and solution was stirred for 10 
minutes. The reaction was quenched by 0.58M Na2S2O3 and stirred for 15 minutes. The organic 
layer was separated, diluted with CH2Cl2, and sequentially washed with 1M HCl, 1M NaOH, and 
water and brine solution. Then solution was dried over MgSO4 and evaporated under reduced 
pressure to obtain (-)-2.27'e as a red viscous oil (580mg, 2 mmol, 100% yield). Dark red oil; 1H 
NMR (300 MHz, CDCl3): δ 7.44-7.31 (m, 6H), 7.21 (s, 1H), 4.21 (q, J=7.03 Hz, 1H), 3.93(br, s, 
2H), 2.43 (s, 3H), 1.75 (d, J=7.03 Hz, 3H). 13C NMR (300 MHz, CDCl3): δ 145.1, 139.7, 131.1, 
131.0, 129.0, 128.4, 127.6, 127.5, 126.8, 111.0, 41.3, 22.1, 20.7 IR (cm-1): 3052, 2977, 2930, 1454, 
1257, 731, 765. MS: HR-ESI calculated for [(C15H16BrN)+H]+: 290.0539, found: 290.0540. [α]D24 
= -9.7° (c= 0.271, CHCl3).  
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2.4.2 Preparation of atropisomeric thiazoline-2-thiones 
 
 General procedure: Following the literature procedure8, a solution of NaOH in water was 
prepared, then a solution of chiral ortho-substituted aniline in DMSO was added, which was stirred 
for few minutes and cooled in an ice-water bath. Carbon disulfide was added to the solution which 
was removed from the ice-water bath and allowed to warm up to room temperature. The solution 
changed from a red to orange color. This solution was again cooled in an ice-water bath. 
Chloroacetone was added drop-wise, then removed from the ice-water bath and allowed to warm 
to room temperature. Then, water was added and a yellowish-orange paste formed. The paste was 
washed with water and dissolved in EtOH. Concentrated HCl was added to it and refluxed for 1 
hour. After cooling the solution to room temperature, the solution was diluted with water and 
concentrated under reduced pressure. The concentrated solution was extracted with CH2Cl2, 
washed with water, and dried over Na2SO4. Flash column chromatography with hexane/ethyl 
acetate eluent separated two diastereomers, usually in 1:1 ratio. In all cases, the (Ra,S)-
diastereomer eluted out first followed by the (Sa,S)-diastereomer. 
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 Preparation of (S)-3-(2,4-dimethyl-6-(1-phenylethyl)phenyl)-4-methylthiazole-2(3H)-
thione (2.28a). To a solution of NaOH/H2O (45.2 mg, 1.96 mmol / 52 µL), a solution of (-)-2.27a 
(225 mg, 1.0 mmol) in DMSO (0.64 mL) was added, followed by the addition of CS2 (70 µL, 1.16 
mmol). Then, chloroacetone (93 µL, 1.16 mmol) was added. Following the general procedure, 
workup and column purification, 90 mg of each (combined yield 54%) crystalline white 
diastereomers were obtained. (Ra,S)-2.28a. 1H NMR (300 MHz, CDCl3): δ 7.39 (s, 1H), 7.20-7.13 
(m, 3H), 7.07 (s, 1H), 7.02-6.99 (m, 2H), 6.16 (s, 1H), 3.98 (q,J=6.9 Hz, 1H), 2.45(s, 3H), 1.92 (s, 
3H), 1.61 (d, J=6.9 Hz, 3H), 1.02 (s, 3H). 13C NMR (300 MHz, CDCl3): δ 188.5, 145.3, 142.9, 
141.2, 140.0, 135.4, 133.0, 130.3, 128.6, 127.7, 126.5, 106.1, 40.6, 23.2, 21.8, 17.6, 14.4 IR (cm-
1): 2975, 1594, 1450, 1335, 1282, 1227, 1141, 1047, 962, 864, 841, 800, 779, 738, 700. M.pt. 173-
175 °C. MS: HR-ESI calculated for [(C20H21NS2)+H]+: 340.1188, found: 340.1182. [α]D25 = 
+44.3° (c= 0.075, CHCl3). HPLC: (1% isopropanol/hexane, ODH column) [9.1 min (minor); 11.0 
min (major)]. ee = 99%. 
(Sa,S)-2.28a. 1H NMR (500 MHz, CDCl3): δ 7.42-7.40 (m, 2H), 7.28-7.27 (m, 1H), 7.25 (s, 1H), 
7.20-7.17 (m, 1H), 7.03 (s, 1H), 6.89 (s, 1H), 6.42 (s, 1H), 3.91 (q, J=7.5 Hz, 1H), 3.29 (s, 3H), 2.04 
(s, 3H), 1.96 (s, 3H), 1.52 (d, J=7.5 Hz, 3H). 13C NMR (500 MHz, CDCl3): δ 189.1, 144.6, 144.3, 
140.1, 140.0, 135.8, 132.5, 130.2, 128.4, 128.4, 128.0, 126.5, 106.9, 39.3, 21.9, 21.6, 18.0, 
15.9. M.pt. 229-231 °C. IR (cm-1): 2979, 1448, 1332, 1280, 1223, 1157, 1136, 1046, 960, 855, 
835, 792, 754, 726, 700. MS: HR-ESI calculated for HR-ESI calculated for [(C20H21NS2)+H]+: 
340.1188, found: 340.1190. [α]D25 = +58.6° (c= 0.016, CHCl3). HPLC: (1% isopropanol/hexane, 
ODH column) [18.3 min (major); 21.5 min (minor)].  ee = 98%. 
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 Preparation of 3-(2-(1-(4-(tert-butyl)phenyl)ethyl)-4,6-dimethylphenyl)-4-
methylthiazole-2(3H)-thione (2.28b). To a solution of NaOH/H2O (120.0 mg, 3.0 mmol / 151 
µL), a solution of (-)-2.27b (816 mg, 3.0 mmol) in DMSO (3.0 mL) was added, followed by the 
addition of CS2 (190 µL, 3.15 mmol). Then, chloroacetone (250 µL, 3.15 mmol) was added. 
Following the general procedure, workup and column purification, 262 mg of each (combined 
yield 44%) pale brown powdered diastereomer was obtained. (Ra,S)-2.28b. 1H NMR (300 MHz, 
CDCl3): δ 7.38 (s, 1H), 7.19 (d, J=8.1 Hz, 2H), 7.05 (s, 1H), 6.93 (d, J=8.1 Hz, 2H), 6.15 (s, 1H), 
3.95 (q,J=7.2 Hz, 1H), 2.45(s, 3H), 1.91 (s, 3H), 1.61 (d, J=7.2 Hz, 3H), 1.26 (s, 9H), 1.00 (s, 
3H). 13C NMR (300 MHz, CDCl3): δ 188.6, 149.5, 143.4, 142.2, 141.3, 139.9, 135.4, 133.0, 130.2, 
127.4, 126.4, 125.4, 106.1, 40.1, 34.5, 31.5, 23.0, 21.9, 17.6, 14.4. M.pt. 175-177 °C. IR (cm-1): 
2961, 1336, 1277, 1225, 1047, 962, 858, 832, 733, 612, 567, 493. MS: HR-ESI calculated for 
[(C24H29NS2)+H]+: 396.1814, found: 396.1814. [α]D25 = +92.3° (c= 0.088, CHCl3). HPLC: (1% 
isopropanol/hexane, ODH column) [7.3 min (minor); 8.1 min (major)]. ee = >99%. 
(Sa,S)-2.28b. 1H NMR (500 MHz, CDCl3): δ 7.33 (d, J=8.1 Hz, 2H), 7.25 (d, , J=8.1 Hz,2H), 6.99 
(s, 1H), 6.89 (s, 1H), 6.39 (s, 1H), 3.82 (q, J=7.2 Hz, 1H), 2.26 (s, 3H), 2.01 (s, 3H), 1.93 (s, 3H), 
1.45 (d, J=7.2 Hz, 3H), 1.26(s, 9H). 13C NMR (500 MHz, CDCl3): δ 189.2, 149.2, 145.0, 141.2, 
140.1, 140.0, 135.8, 132.4, 130.2, 128.1, 128.0, 125.3, 106.8, 38.7, 34.5, 31.6, 21.9, 21.7, 18.0, 
15.9. M.pt. 200-202 °C.  IR (cm-1): 2963, 1330, 1278, 1226, 1149, 1045, 962, 861, 835, 728, 565, 
489. MS: HR-ESI calculated for [(C24H29NS2)+H]+: 396.1814, found: 396.1704. [α]D25 = +65.6° 
(c= 0.078, CHCl3). HPLC: (1% isopropanol/hexane, ADH column) [12.0 min (major); 15.7 min 
(minor)]. ee = 99%. 
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 Preparation of 3-(2,4-dimethyl-6-(1-(naphthalen-1-yl)ethyl)phenyl)-4-methylthiazole-
2(3H)-thione (2.28c). To a solution of NaOH/H2O (45 mg, 1.13 mmol / 1 drop water), a solution 
of (-)-2.27c (275 mg, 1.0 mmol) in DMSO (1.5 mL) was added, followed by the addition of CS2 
(60 µL, 1.0 mmol). Then, chloroacetone (80 µL, 1.08 mmol) was added. Following the general 
procedure, workup and column purification, 134 mg each (combined yield 69%) white powdered 
diastereomer was obtained. (Ra,S)-2.28c. 1H NMR (300 MHz, CDCl3): δ 7.97 (s, 1H), 7.74 (s, 1H), 
7.58 (d, J=8.1 Hz, 1H), 7.52 (s, 1H), 7.39-7.36 (m, 2H), 7.22 (d, J=7.5 Hz, 1H), 7.13 (d, J=6.9 Hz, 
1H), 7.05 (s, 1H), 5.47 (s, 1H), 4.98 (q,J=7.2 Hz, 1H), 2.48(s, 3H), 1.80 (s, 3H), 1.65 (d, J=7.2 Hz, 
3H), 0.63 (s, 3H). 13C NMR (300 MHz, CDCl3): δ 188.3, 143.2, 142.2, 140.6, 139.9, 135.7, 133.8, 
133.2, 131.3, 130.4, 128.6, 127.1, 126.7, 126.5, 125.8, 125.5, 125.5, 122.8, 106.0, 34.6, 22.5, 21.9, 
17.6, 13.9. M.pt. 245-246 °C. IR (cm-1): 2969, 1590, 1455, 1383, 1337, 1280, 1229, 1146, 1051, 
965, 864, 839, 799, 780, 737. MS: HR-ESI calculated for [(C24H23NS2)+H]+: 390.1345, found: 
390.1246. [α]D25 = -123.1° (c= 0.026, CHCl3). HPLC: (5% isopropanol/hexane, ODH column) 
[8.1 min (minor); 10.3 min (major)].  ee = 99%. 
(Sa,S)-2.28c. 1H NMR (300 MHz, CDCl3): δ 8.14(d, J=7.8 Hz,1H), 7.81 (d, J=7.8 Hz,1H), 7.70 
(d,  J=7.5 Hz,1H), 7.44-7.31 (m, 4H), 7.09 (d,  J=7.5 Hz,1H), 6.24 (s, 1H), 4.80 (q, J=7.8 Hz, 1H), 
2.34 (s, 3H), 2.01 (s, 3H), 1.75 (s, 3H), 1.69 (d, J=7.8 Hz, 3H). 13C NMR (300 MHz, CDCl3): δ 
188.5, 142.7, 140.1, 139.9, 139.6, 136.6, 134.0, 132.9, 131.9, 130.5, 128.9, 128.4, 127.1, 126.0, 
125.8, 125.4, 125.4, 123.7, 107.2, 36.6, 21.9, 21.7, 17.9, 15.7 M.pt. 167-169 °C.  IR (cm-1): 2979, 
1594, 1469, 1334, 1283, 1225, 1157, 1130, 1047, 999, 952, 862, 841, 801, 778, 735. MS: HR-ESI 
calculated for [(C24H23NS2)+H]+: 390.1345, found: 390.1240. [α]D25 = +80.01° (c= 0.026, CHCl3). 
HPLC: (5% isopropanol/hexane, ODH column) [14.4 min (minor); 23.9 min (major)]. ee = 97%. 
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 Preparation of (2,4-dimethyl-6-(1-(naphthalen-2-yl)ethyl)phenyl)-4-methylthiazole-
2(3H)-thione (2.27d). To a solution of NaOH/H2O (58 mg, 1.45 mmol / 70 µL), a solution of (-)-
2.27d (400 mg, 1.45 mmol) in DMSO (2.0 mL) was added, followed by the addition of CS2 (88 
µL, 1.47 mmol). Then, chloroacetone (121 µL, 1.47 mmol) was added. Following the general 
procedure, workup and column purification, 56 mg of each (combined yield 20%) yellow 
powdered diastereomer was obtained. (Ra,S)-2.28d. 1H NMR (300 MHz, CDCl3): δ 7.77-7.74 (m, 
1H), 7.70-7.69 (m, 2H), 7.45-7.41 (m, 3H), 7.36 (s, 1H), 7.23-7.20 (m, 1H), 7.09 (s, 1H), 6.06 (s, 
1H), 4.20  (q,J=6.9 Hz, 1H), 2.48(s, 3H), 1.92 (s, 3H), 1.69 (d, J=6.9 Hz, 3H), 0.85 (s, 
3H). 13C NMR (500 MHz, CDCl3): δ 188.5, 142.6, 142.5, 141.1, 140.0, 135.6, 133.6, 133.2, 132.3, 
130.5, 128.3, 127.7, 127.7, 126.6, 126.3, 126.2, 126.0, 125.7, 106.0, 40.8, 22.8, 21.9, 17.6, 14.4. 
M.pt. 125-128 °C.  IR (cm-1): 2967, 2926, 1589, 1451, 1276, 1061, 906, 857, 822, 728, 479. MS: 
HR-ESI calculated for [(C24H23NS2)+H]+:390.1345, found: 390.1346. [α]D25 = +110.2° (c= 0.30, 
CHCl3). HPLC: (1% isopropanol/hexane, ODH column) [12.1 min (minor); 18.0 min (major)]. ee 
= 98%. 
(Sa,S)-2.28d. 1H NMR (500 MHz, CDCl3): δ 7.81-7.77(m, 3H), 7.70 (d, J=8.5 Hz,1H), 7.63 (d,  
J=8.5 Hz,1H), 7.44-7.41 (m, 2H), 7.02 (s, 1H), 6.81 (s, 1H), 6.42 (s, 1H), 4.10 (q, J=7.3 Hz, 1H), 
2.22 (s, 3H), 2.05 (s, 3H), 1.98 (s, 3H), 1.60 (d, J=7.3 Hz, 3H). 13C NMR (500 MHz, CDCl3): δ 
189.2, 144.7, 142.0, 140.1, 135.7, 133.5, 132.6, 132.5, 130.3, 128.4, 128.1, 128.1, 127.9, 127.7, 
125.9, 125.8, 125.5, 107.4, 39.2, 21.6, 21.5, 17.9, 15.9 M.pt. 149-152 °C.  IR (cm-1): 2969, 2926, 
1597, 1473, 1282, 1050, 904, 854, 809, 730, 648, 479. MS: HR-ESI calculated for 
[(C24H23NS2)+H]+:390.1345, found:390.1348. [α]D25 = +37.8° (c= 0.027, CHCl3). HPLC: (1% 
isopropanol/hexane, ADH column) [32.6 min (minor); 44.7 min (major)]. ee = 99%. 
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 Preparation of (2-bromo-4-methyl-6-(1-phenylethyl)phenyl)-4-methylthiazole-2(3H)-
thione (2.28e). To a solution of NaOH/H2O (76 mg, 1.9 mmol / 84 µL), a solution of (-)-2.27'e 
(522 mg, 1.8 mmol) in DMSO (2.0 mL) was added, followed by the addition of CS2 (113 µL, 1.9 
mmol). Then, chloroacetone (151 µL, 1.9 mmol) was added. Following the general procedure, 
workup and column purification, 28 mg of (Sa,S)-2.28e pale yellow crystalline and 18 mg (Ra,S)-
2.28e. yellow powdered solid were obtained in 1.5:1 ratio (combined yield 6%). (Ra,S)-2.28e. 1H 
NMR (300 MHz, CDCl3): δ 7.49-7.49 (m, 2H), 7.22-7.14 (m, 3H), 6.99-6.961 (m, 2H), 6.14 (s, 
1H), 4.07  (q,J=7.5 Hz, 1H), 2.48(s, 3H), 1.61 (d, J=7.5 Hz, 3H), 1.08 (s, 3H). 13C NMR (300 
MHz, CDCl3): δ 189.0, 145.8, 144.6, 141.9, 141.2, 133.0, 132.4, 128.8, 127.9, 127.7, 126.8, 123.0, 
106.0, 41.4, 22.8, 21.7, 14.5. M.pt. 159-161 °C.  IR (cm-1): 3092, 1590, 1449, 1342, 1280, 1258, 
1232, 1143, 1041, 960, 857, 801, 781, 763, 723, 701. MS: HR-ESI calculated for 
[(C19H18BrNS2)+Na]+: 425.9956, found: 425.9952.   [α]D25 = + 61.6° (c= 0.125, CHCl3). HPLC: 
(1% isopropanol/hexane, ODH column) [14.8 min (major); 20.9 min (minor)]. ee = 87%. 
(Sa,S)-2.28e. 1H NMR (500 MHz, CDCl3): δ 7.43 (m, 3H), 7.31-7.28 (m, 1H), 7.25-7.18 (m, 2H), 
6.95 (s, 1H), 6.41 (s, 1H), 4.10 (q, J=7.0 Hz, 1H), 2.28 (s, 3H), 2.02 (s, 3H), 1.49 (d, J=7.0 Hz, 
3H). 13C NMR (500 MHz, CDCl3): δ 189.6, 147.8, 143.5, 142.0, 139.0, 132.4, 129.8, 128.5, 128.5, 
126.9, 123.1, 107.0, 40.0, 21.5, 21.5, 16.0 M.pt. 174-176 °C.  IR (cm-1): 2915, 1590, 1450, 1378, 
1336, 1280, 1226, 1137, 1035, 960, 856, 835, 776, 725, 700. MS: HR-ESI calculated for 
[(C19H18BrNS2)+H]+: 404.0137, found: 404.0064. [α]D22 =  +11.1° (c= 0.018, CHCl3). HPLC: 
(1% isopropanol/hexane, ODH column) [13.7 min (minor); 20.6 min (major)]. ee = 99%. 
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2.4.3 Preparation of thiazolium salts. 
 
 Following literature procedure8, thiazoline-2-thiones were oxidized with 30% H2O2 in 
acetic acid into their corresponding thiazolylidine NHC precatalysts. The progress of the reaction 
was monitored by TLC. After the completion of the reaction, acetic acid was removed by co-
evaporation with toluene.  
 Preparation of (3-(2,4-dimethyl-6-(1-phenylethyl)phenyl)-4-methylthiazol-3-ium 
hydrogen sulfate (2.29a). To a solution of 2.28a (31 mg, 0.091 mmol) in 0.5 mL acetic acid, H2O2 
(25 µL) was added and stirred at room temperature for 90 minutes. AcOH was removed by co-
evaporation with toluene to obtain 2.29a as a crystalline white solid (36.5 mg, >99% yield). 1H 
NMR (300 MHz, CDCl3): δ 8.59 (s, 1H), 8.16 (s, 1H), 7.36 (s, 1H), 7.24-7.13 (m, 4H), 6.76-6.73 
(m, 2H), 3.46 (q, J=7.0 Hz, 1H), 2.48 (s, 3H), 2.28 (s, 3H), 1.87 (s, 3H), 1.56 (d, J=7.0Hz, 
3H). 13C NMR (300 MHz, CDCl3): δ 159.8, 145.9, 144.4, 142.6, 140.3, 135.0, 132.0, 131.3, 129.5, 
127.6, 127.4, 126.7, 122.7, 41.0, 22.4, 21.8, 17.4, 13.5 IR (cm-1): 3101, 1597, 1451, 1283, 1229, 
1050, 917, 863, 840, 769, 736, 703, 621. MS: HR-ESI calculated for (C20H22NS)+: 308.1467, 
found: 308.1463; HR-ESI calculated for (HSO4)-: 96.9601, found: 96.9573. 
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 Preparation of (3-(2-(1-(4-(tert-butyl)phenyl)ethyl)-4,6-dimethylphenyl)-4-
methylthiazol-3-ium hydrogen sulfate (2.29b). To a solution of 2.28b (32 mg, 0.081 mmol) in 
0.5 mL acetic acid, H2O2 (25 µL) was added and stirred at room temperature for 50 minutes. AcOH 
was removed by co-evaporation with toluene to obtain 2.29b as a crystalline white solid (37 mg, 
>99% yield). 1H NMR (500 MHz, CDCl3): δ 8.55 (s, 2H), 7.32 (s, 1H), 7.23 (s, 2H), 7.13 (s, 1H), 
6.72 (s, 2H), 3.43 (q, J=7.0 Hz, 1H), 2.47 (s, 3H), 2.27 (s, 3H), 1.91 (s, 3H), 1.54 (d, J=7.0Hz, 
3H), 1.26 (s, 9H). 13C NMR (500 MHz, CDCl3): δ 158.9, 150.4, 145.5, 142.2, 141.3, 141.0, 135.3, 
132.2, 131.1, 127.3, 126.7, 126.3, 124.7, 40.3, 34.7, 31.6, 22.5, 21.8, 17.7, 13.5 IR (cm-1): 2967, 
1604, 1566, 1511, 1214, 1060, 835, 744, 666, 583. MS: HR-ESI calculated for (C24H30NS)+: 
364.2093, found: 364.2120. HR-ESI calculated for (HSO4)-: 96.9601, found: 96.9536. 
 Preparation of (2,4-dimethyl-6-(1-(naphthalen-1-yl)ethyl)phenyl)-4-methylthiazol-3-
ium hydrogen sulfate (2.29c). To a solution of 2.28c (39.5 mg, 0.10 mmol) in 0.5 mL acetic acid, 
H2O2 (30 µL) was added and stirred at room temperature for 60 minutes. AcOH was removed by 
co-evaporation with toluene to obtain 2.29c as a yellow oil product (45 mg, >99% yield).1H 
NMR (300 MHz, CDCl3): δ 8.32 (s, 1H), 8.00 (s, 1H), 7.77- 7.59 (m, 3H), 7.48 (s, 1H), 7.44-7.36 
(m, 2H), 7.33-7.28 (m, 1H), 7.14 (s, 1H), 6.88(d, J=7.2 Hz, 1H), 4.39 (q, J=6.9 Hz, 1H), 2.51 (s, 
3H), 2.05 (s, 3H), 1.77 (s, 3H), 1.69 (d, J=6.9 Hz, 3H). 13C NMR (300 MHz, CDCl3): δ 159.4, 
145.3, 142.2, 141.1, 140.3, 135.8, 133.7, 132.0, 131.2, 130.5, 129.3, 128.1, 127.9, 127.3, 126.4, 
126.2, 124.7, 123.6, 121.7, 36.6, 21.8, 21.4, 17.4, 13.0.  IR (cm-1): 2976, 1569, 1450, 1217, 1162, 
1060, 857, 804, 781, 750, 582. MS: HR-ESI calculated for (C24H24NS)+: 358.1624, found: 
358.1651. HR-ESI calculated for (HSO4)-: 96.9601, found: 96.9555. 
 Preparation of 3-(2,4-dimethyl-6-(1-(naphthalen-2-yl)ethyl)phenyl)-4-methylthiazol-3-
ium hydrogen sulfate (2.29d). To a solution of 2.28d (39.5 mg, 0.10 mmol) in 0.5 mL acetic acid, 
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H2O2 (30 µL) was added and stirred at room temperature for 3 hours. AcOH was removed by co-
evaporation with toluene to obtain 2.29d as a yellow oil product (29 mg, 64% yield).1H NMR (500 
MHz, CDCl3): δ 8.68-8.66 (m, 2H), 7.77-7.70 (m, 3H), 7.46-7.44 (m, 2H), 7.40 (s, 1H), 7.18 (s, 
2H), 6.96 (s, 1H), 3.64 (q, J=7.0 Hz, 1H), 2.50 (s, 3H), 2.27 (s, 3H), 1.86 (s, 3H), 1.65 (d, J=7.0Hz, 
3H). 13C NMR (500 MHz, CDCl3): δ 159.5, 145.7, 142.3, 141.6, 141.0, 135.1, 133.5, 132.4, 132.1, 
131.1, 129.3, 128.1, 127.8, 127.5, 126.7, 126.1, 125.7, 125.3, 124.8, 40.4, 22.2, 21.7, 17.5, 13.4  
IR (cm-1): 3014, 1604, 1571, 1214, 1047, 858, 743, 666, 581, 478. MS: HR-ESI calculated for 
(C24H24NS)+: 358.1624, found: 358.1656. HR-ESI calculated for (HSO4)-: 96.9601, found: 
96.9587. 
 Preparation of (2-bromo-4-methyl-6-(1-phenylethyl)phenyl)-4-methylthiazol-3-ium 
hydrogen sulfate (2.29e). To a solution of 2.28e (33.7 mg, 0.08 mmol) in 0.5 mL acetic acid, 
H2O2 (25µL) was added and stirred at room temperature for 90 minutes. AcOH was removed by 
co-evaporation with toluene to obtain 2.29e as a yellow oil product (41 mg, >99% yield).1H 
NMR (300 MHz, CDCl3): δ 8.67 (s, 1H), 8.60 (s, 1H), 7.52 (s, 1H), 7.49 (s, 1H), 7.28-7.16 (m, 
3H), 6.88 (m, 2H), 3.71 (q, J=6.9 Hz, 1H), 2.52 (s, 3H), 2.33 (s, 3H), 1.58 (d, J=6.9 Hz, 
3H). 13C NMR (300 MHz, CDCl3): δ 159.6, 145.8, 144.4, 143.9, 143.7, 132.9, 131.9, 129.7, 129.1, 
127.8, 127.2, 125.1, 121.4, 41.4, 22.4, 21.8, 13.8.  IR (cm-1): 2973, 1598, 1568, 1452, 1168, 1060, 
854, 762, 704, 584. MS: HR-ESI calculated for (C20H19BrNS)+: 372.0416, found: 372.0420; HR-
ESI calculated for (HSO4)-: 96.9601, found: 96.9593. 
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30% H2O2
AcOH
(Ra,S)-2.28a (Sa,S)-2.29a
N
Me
S
Me
Ph
Me
S Me
H
N
Me
S
H
Me
Ph
Me
Me
HSO4
H
 
 Preparation of 3-(2,4-dimethyl-6-(1-phenylethyl)phenyl)-4-methylthiazol-3-ium 
hydrogen sulfate (Sa,S)-2.29. To a solution of (Ra,S)-2.28 (60 mg, 0.18 mmol) in 1.0 mL acetic 
acid, H2O2 (97 µL) was added and stirred at room temperature for 4 hours. AcOH was removed 
by co-evaporation with toluene to obtain a colorless oily product (43 mg, 0.11 mmol,59% yield).1H 
NMR (300 MHz, CDCl3): δ 10.18 (s, 1H), 8.03 (s,1H), 7.32 (s, 1H), 7.14-7.7.04 (m, 4H), 8.16 (s, 
1H), 6.78-6.75 (m, 2H), 3.81 (q, J=6.6 Hz, 1H), 2.42 (s, 3H), 1.81 (s, 3H), 1.52 (d, J=6.6 Hz, 3H), 
1.32 (s, 3H). 13C NMR (300 MHz, CDCl3): δ 161.2, 146.5, 144.0, 141.8, 141.2, 134.8, 132.4, 
130.5, 129.0, 127.5, 127.1, 126.8, 123.7, 40.1, 22.8, 21.7, 17.4, 12.1. IR (cm-1): 2923, 1601, 1451, 
1157, 1044, 960, 836, 768, 737, 702, 576. MS: HR-ESI calculated for [(C20H23NO4S2)+H]+: 
406.0678, found: 406.1152. 
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(Ra,S)-2.29a perchlorate(Ra,S)-2.29a hydrogen sulfate
NaClO4
MeOH:H2O
ClO4HSO4
N
Me
Me
Me
Ph
S
Me
H
H N
Me
Me
Me
Ph
S
Me
H
H
 
 3-(2-chloro-4-methyl-6-(1-phenylethyl)phenyl)-4-methylthiazol-3-ium perchlorate 
(2.29a perchlorate). To a solution of 2.29a hydrogen sulfate (240 mg, 0.57 mmol) in 0.43 mL 
methanol in an ice-water bath, a solution of NaClO4 (2.8 mL, 310 mg, 2.53 mmol) in MeOH: H2O 
(2:1) was added drop-wise and stirred for 1 hour. A white precipitate was observed, which was 
filtered and dried under vacuum to obtain 2.29a perchlorate (210 mg, 0.51 mmol, 89% yield).  1H 
NMR (500 MHz, CDCl3): δ 8.60 (s, 1H), 8.16 (s, 1H), 7.36 (s, 1H), 7.21-7.16 (m, 4H), 6.75-6.74 
(m, 2H), 3.47 (q, J=7.0 Hz, 1H), 2.48 (s, 3H), 2.28 (s, 3H), 1.87 (s, 3H), 1.56 (d, J=7.0Hz, 
3H). 13C NMR (500 MHz, CDCl3): δ 159.8, 145.9, 144.4, 142.6, 140.3, 135.0, 132.0, 131.3, 129.5, 
127.6, 127.4, 126.7, 122.7, 40.9, 22.4, 21.8, 17.4, 13.5. IR (cm-1): 3103, 1602, 1451, 1073, 917, 
862, 772, 735, 706, 622. MS: HR-ESI calculated for (C20H22NS)+: 308.1467, found: 308.1469; 
HR-ESI calculated for (ClO4)-: 98.9491, found: 98.9436. 
2.4.4 General procedure for benzoin condensation. 
 In a vial containing a catalyst under argon, the appropriate amount of solvent, 
benzaldehyde, base, and brønsted acid were added. The solution was stirred at room temperature 
and the reaction was progressively monitored via TLC and 1H NMR. After the completion of the 
reaction, the solution was quenched by acetic acid, diluted with water and extracted multiple times 
with CH2Cl2. The combined organic phases were dried over MgSO4, concentrated under reduced 
pressure and purified via flash column chromatography using hexane/ethyl acetate as eluent. Their 
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enantiomeric ratios were determined by chiral HPLC. The absolute stereochemistry of benzoin11 
was determined to be (S)-configuration based on analogy from optical rotation and retention time 
of major peak. (Sa,S)-2.29a produced (R)-configuration. 
2.4.5 X-ray experimental procedure (This experimental procedure is provided by Emily 
Reeves). 
 Using Olex2,13 the structure of (Ra,R)-2.28a was solved with the ShelXS14 structure 
solution program using direct methods. Refinement was performed in Olex2 using the SHELXL 
least squares refinement method. A final R1 value of 4.88% was obtained. The Flack parameter 
was 0.00(5), indicating the correct assignment of electron density at the chiral center C13. 
Inversion of the structure afforded a Flack parameter of 1.00. In order to verify the (Ra,R)-2.28a, 
we attempted to solve the crystal structure by reversing the assignments of S1-C4 and S2-C2, as 
we would expect to assign for the (Sa,S)-2.28a. Refinement yielded a poor fit (GooF = 2.252 and 
R1=26.87%) for the backward conformer. The crystallographic data file for (Ra,R)-2.28a has been 
deposited with the Cambridge Crystallographic Data Center (CCDC) as CCDC number 1502532. 
This data is obtainable free of charge by application to the director at CCDC, 12 Union Road, 
Cambridge, CB21EZ, UK (Fax: (+44)1223-336-033; email deposit@ccdc.cam.ac.uk). 
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2.4.6 Crystal data and structure refinement parameters  
(Structure refinement parameters are provided by Emily Reeves). 
Crystal data and structure refinement for (Ra,R)-2.28a (CCDC 1502532) 
Bond precision 
Wavelength 
Empirical formula 
C-C = 0.0061Å 
0.71073 
C20H21NS2 
Formula weight 339.50 
Temperature/K 100.02 
Crystal system orthorhombic 
Space group P212121 
a/Å 8.923(3) 
b/Å 11.020(4) 
c/Å 18.001(7) 
α/° 90 
β/° 90 
γ/° 90 
Volume/Å3 1770.1(12) 
Z 4 
ρcalcg/cm3 1.274 
μ/mm-1 0.300 
F(000) 720.0 
Crystal size/mm3 0.387 × 0.106 × 0.079 
Radiation MoKα (λ = 0.71073) 
2Θ range for data collection/° 4.334 to 53.502 
Index ranges -11 ≤ h ≤ 9, -13 ≤ k ≤ 13, -22 ≤ l ≤ 22 
Reflections collected 32094 
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Independent reflections 3699 [Rint = 0.1098, Rsigma = 0.0731] 
Data/restraints/parameters 3699/0/248 
Goodness-of-fit on F2 0.982 
Final R indexes [I>=2σ (I)] R1 = 0.0488, wR2 = 0.1169 
Final R indexes [all data] R1 = 0.0678, wR2 = 0.1238 
Largest diff. peak/hole / e Å-3 0.44/-0.36 
Flack parameter 0.00(5) 
Correction method (# rep. T limits) Tmin = 0.685, Tmax = 0.862 
AbsCorr Multi-scan 
Data completeness 1.72/0.99 
Θmax 26.751 
R(reflections) 0.0488(2919) 
wR2(reflections) 0.1238(3699) 
S 0.982 
Npar 248 
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Chapter 3: Synthesis of chiral anilines 
3.1 Microwave assisted alkylation of anilines 
In the course of our studies of axially chiral NHCs described in the preceding sections of 
this chapter, we required rapid access to variously substituted chiral ortho-(1-arylethyl)anilines. 
Among several published methods for the preparation of this family of compounds,1-3 alkylation 
of anilines with vinylarenes in the presence of Brønsted acids appeared to be particularly 
straightforward. Coates’ protocol,1b which called for heating the reactants in xylene in the presence 
of sub stoichiometric amounts of triflic acid, was deemed especially suitable for the synthesis of 
1-phenylethyl- and 1-(4-tert-butylphenyl)ethyl-anilines starting from the inexpensive styrene and 
4-tert-butylstyrene, respectively. However, when we decided to access anilines with a more 
diverse set of aryl groups, we realized that many of the other requisite vinylarenes were 
prohibitively expensive. This limitation would become especially severe in the synthesis of 2,6-
di(1-arylethyl)anilines, which, according to the original procedure, called for using 10 equivalents 
of the vinylarene (5-fold excess) relative to the aniline. Besides, the reactions required long 
reaction times (typically 20-24 h). With these considerations in mind, we sought to improve 
Coates’ protocol. 
 Microwave irradiation offers a convenient alternative to conventional heating, sometimes 
resulting in dramatically shortened reaction times.4 Surprisingly, we were able to find only one 
example of microwave-assisted o-alkylation of anilines, and even that was in a dismal yield.5 
Nonetheless, we were pleased to discover that alkylation of 2,4-dimethylaniline with styrene 
proceeded in a matter of minutes on heating in a household microwave oven in an open flask. No 
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co-solvent was required, which facilitated the work-up and purification. After some 
experimentation, we found it optimal to introduce the styrene in several portions and deliver 
microwave irradiation in several 30 s blasts at ca. 630 W power (70% setting on a 900 W oven). 
The desired product was isolated in 70% yield (Table 3.1, entry 1).  Similar yields were realized 
when styrene was replaced with p-tert-butylstyrene or 2,4,6-trimethylstyrene (Table 3.1, entries 2 
and 3). At this point, we examined the possibility of replacing vinylarenes with 1-arylethanols.6 
We reasoned that these intermediates would be easily accessible from aryl methyl ketones and 
aromatic aldehydes, which are typically much less expensive and commercially available in a 
greater variety than the corresponding vinylarenes. Pleasingly, 1-phenylethanol reacted with 2,4-
dimethylaniline under the same conditions as did styrene and produced essentially the same yield 
(entry 4). NMR analysis of the reaction mixture indicated that the starting alcohol disappeared 
almost completely after the first microwave blasts. In addition to the alkylated aniline, substantial 
amounts of styrene were produced, which were converted to the final product on continued 
irradiation. With this result in hand, we prepared several additional 1-arylethanols and examined 
their reactivity in the alkylation of 2,4-dimethylaniline. Moderate to good yields were obtained in 
most cases (entries 5-9). However, when the alcohol contained the strongly electron-withdrawing 
nitro or trifluoromethyl groups, the reaction failed completely and only decomposition of the 
starting materials was observed (entries 10 and 11). Also, when 2,4-dimethylaniline was replaced 
with 4-chloro- or 4-bromo-2-methylaniline, the yield in alkylation with styrene dropped 
significantly (entries 12 and 13). 
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Table 3.1: Monoalkylation of 2,4-dimethylaniline 
 
Entry(a) R Ar, 3.02or 3.03 % yield 
1 Me Ph (3.02) 70 
2 Me 4-t-BuC6H4 (3.02) 75 
3 Me 2,4,6-Me3C6H2 (3.02) 59 
4 Me Ph (3.03) 69 
5 Me 2,4,6-Me3C6H2 (3.03) 59 
6 Me 2-MeC6H4 (3.03) 62 
7 Me 1-naphthyl (3.03) 82 
8 Me 2-naphthyl (3.03) 83 
9 Me 2-MeOC6H4 (3.03) 71 
10 Me 3-O2NC6H4 (3.03) 0 
11 Me 3,5-(CF3)2C6H3 (3.03) 0 
12 Cl Ph (3.02) 45 
13 Br Ph (3.02) 24 
a) Conditions: 1 (20 mmol), 3.02 or 3.03 (18 mmol), CF3SO3H (2.3 mmol), four to six 30 
seconds µW blasts at 630 W. 
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 Scope and limitations of the new procedure were examined next. In particular, we were 
interested in reducing the 500% excess of alkylating agent used in the original protocol to bring 
about bis-alkylation of ortho-unsubstituted anilines. Even though we did not think we would need 
C2-symmetrical 2,6-bis(1-arylalkyl)anilines for our project, they have found applications 
elsewhere in catalysis.3b  As expected, gradual addition of styrene to p-toluidine under microwave-
assisted conditions resulted in mixtures of the unreacted aniline and its mono- and bis-ortho-
substituted derivatives.  The monoalkylated product was best obtained using styrene as the limiting 
reagent (Table 3.2, entry 1). Continued addition of styrene into the reaction mixture (up to 2 
equivalents) afforded 74% yield of the doubly substituted product (Table 3.2, entry 2). Para-tert-
butylstyrene and 1-arylethanols reacted n a similar manner (Table 3.2, entries 3-8). The effect of 
the para-substituent on the aniline was explored briefly. Both p-anisidine and p-chloroaniline 
produced results comparable to those obtained with p-toluidine (Table 3.2, entries 9-12 vs. 1 and 
2). 
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Table 3.2: Mono- and bis-alkylation of p-substituted anilines. 
 
Entry R (mmol) Ar (3.02 or 3.03, mmol)  TfOH 
(mL) 
% (yield)a 
1 Me (40) Ph (3.02, 28) 0.2 59 (3.06) 
2 Me (20) Ph (3.02, 40) 0.3 74 (3.07) 
3 Me (30) 4-t-BuC6H4 (3.02, 20) 0.2 52 (3.06) 
4 Me (20) 4-t-BuC6H4 (3.02, 45) 0.3 93 (3.07) 
5 Me (10) 2,4,6-Me3C6H2 (3.03, 5.2) 0.15 72 (3.06) 
6 Me (10) 2,4,6-Me3C6H2 (3.03, 22) 0.2 55 (3.07) 
7 Me (30) 2-naphthyl (3.03, 15) 0.2 72 (3.06) 
8 Me (10) 2-naphthyl (3.03, 22) 0.2 89 (3.07) 
9 OMe (20) Ph (3.02, 15) 0.2 48 (3.06) 
10 OMe (10) Ph (3.02, 22) 0.15 51 (3.07) 
11 Cl (30) Ph (3.02, 20) 0.2 79 (3.06) 
12 Cl (20) Ph (3.02, 42) 0.2 78 (3.07) 
a) Yields are based on the limiting reagent. 
In the course of our experiments, we noticed that the triflate salts of unreacted anilines 
often precipitate from crude reaction mixtures upon dilution with the hexane-ethyl acetate 
chromatographic eluent. Taking advantage of this observation, we carried out large-scale (81 
mmol) alkylation of 2,4-dimethylaniline 3.01 (Table 3.1, entry 1) with styrene, recovered ca. 70% 
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of pure 2,4-dimethylanilinium triflate by simple filtration and used it twice to catalyze the same 
reaction on progressively smaller scale (50 and 36 mmol). Pure 2,4-dimethyl-6-(1-
phenylethyl)aniline 3.04 (Table 3.2, entry 1)  was easily obtained from the crude mixture in 64% 
unoptimized yield by recrystallization from hexane. 
 In conclusion, our modified alkylation procedure proved to be successful and more 
convenient than Coates’ original protocol, and allowed us to prepare several chiral anilines that 
we needed for our NHC project. Perhaps, the only problem was that the use of domestic microwave 
ovens is no longer deemed acceptable for publication in most journals, because of potential safety 
concerns. Thus, even though we never experienced any problems in the course of this study, it may 
have to be repeated in a laboratory-grade microwave reactor in order to facilitate its publication. 
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3.2 Experimental 
All reagents were obtained commercially and used as received, unless specified otherwise. 1-
Arylethanols were prepared via borohydride reduction of the corresponding ketones or addition 
of methylmagnesium bromide to the corresponding aldehydes and used without additional 
purification. Microwave-assisted reactions were carried out in a Magic Chef® household 
microwave oven (Model MCD 990b, 900 W, 9 cu. ft.) Solvents used for chromatography were 
ACS grade. Reactions were monitored by thin layer chromatography (TLC) and by 1H 
NMR. Uniplate silica gel 250 HLF plates were used for TLC analyses. Flash column 
chromatography was performed over Sorbtech silica gel (40-63mm). 1H NMR and 13C NMR 
spectra were recorded on a Mercury 300 MHz Varian Spectrometer. The chemical shifts are 
reported as δ (ppm) relative to TMS using residual CHCl3 peak (7.26 ppm) as the reference. High- 
Resolution mass spectral analyses were performed at Washington University MS Center on 
a Kratos MS-50TA spectrometer using Electrospray Ionization (ESI) method. Infrared spectra 
were recorded on a Perkin-Elmer Spectrum Bx FTIR spectrophotometer using potassium bromide 
plates or on a Bruker Alpha Platinum-ATR. Melting points were measured on a Stuart SMP 10 
melting point apparatus. 
Note: Efficacy of microwave irradiation depends on the sample size, its position in the 
chamber, physical properties of the reaction mixture, glassware used and other experimental 
factors. Therefore, irradiation times and power levels given below should be adjusted depending 
on the setup used and may need to be further optimized for individual reactions.   
Monoalkylation on exploratory scale: A substituted aniline (20 mmol) was treated 
with trifluoromethanesulfonic acid (0.20 mL, 0.34 g, 2.3 mmol) in a 50-100 mL round-
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bottom flask (Caution! Exothermic reaction!) An alkylating agent (vinylarene or 1-
arylethanol, 0.5-0.9 equiv) was added into the flask in four roughly equal portions, each followed 
by a 20-30 sec irradiation blast at 70% power level. (Note: the flask may be fitted with a low-
profile air condenser to minimize the loss of volatile reactants). To monitor the reaction 
progress, samples were withdrawn with a glass rod or a thermometer after each blast, dissolved 
in deuterated chloroform and analyzed by TLC or 1H NMR.  After completing the addition, the 
mixture was irradiated two more times using the same settings, then allowed to cool to room 
temperature, diluted with a minimal amount of dichloromethane, loaded on a silica gel column and 
eluted with hexane-ethyl acetate (24:1).  
Bisalkylations: Bisalkylations were performed analogously, except that the alkylating 
agent (2.0-2.25 equivalents relative to the aniline) was introduced in eight portions. Meso- and dl-
diastereomers of the bisalkylated products 3.07 were formed in comparable amounts and in some 
cases (see Characterization Data) could be separated by conventional flash chromatography. Only 
small amounts of monoalkylated products 3.06 were present in the crude reaction mixture.  
 Large-scale preparation of 2,4-dimethyl-6-(1-phenylethyl)-aniline 3.4a with catalyst 
recycling. (a) To 2,4-dimethylaniline (10 mL, 81 mmol) in a 100 mL flask equipped with an air 
condenser was added trifluoromethanesulfonic acid (1.00 mL, 11.3 mmol). The mixture was 
heated for 30 s at 100% power in a household microwave oven (900 W power rating) reaching ca. 
160° C final temperature. Styrene (9.3 mL, 81 mmol) was introduced in four roughly equal 
portions, each followed by a 30 sec irradiation blast at 80% power level, plus once more after 
completing the addition (final temperature 200-210 °C). The reaction mixture was allowed to cool 
to room temperature and diluted with 20 mL of hexane/ethyl acetate 9:1 mixture. After 15 minutes 
a precipitate was filtered off, rinsed with 10 mL of the same solvent mixture, and air dried. 2,4-
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Dimethylanilinium triflate was thus obtained in the form of off-white fluffy needles (2.20 g, 72% 
recovery based on trifluoromethanesulfonic acid). The deep-brown filtrate was saved.  
 (b) The above procedure was repeated on a smaller scale using the recovered 2,4-
dimethylanilinium triflate (2.20 g, 8.11 mmol) instead of trifluoromethanesulfonic acid, 2,4-
dimethylaniline base (6.2 mL, 50 mmol), and styrene (6.7 mL, 58 mmol). All microwave 
irradiations were performed at 70% power level. 1.56 g of 2,4-dimethylanilinium triflate was 
recovered by filtration (71% recovery). 
 c) The above procedure was repeated on a smaller scale using the recovered 2,4-
dimethylanilinium triflate (1.56 g, 5.76 mmol), 2,4-dimethylaniline base (4.4 mL, 35.6 mmol), and 
styrene (4.7 mL, 41 mmol). 1.01 g of 2,4-dimethylanilinium triflate was recovered by filtration 
(65% recovery).  
(d) The filtrates obtained in the above experiments were combined and passed through a 2 
cm plug of silica gel in a fritted-glass funnel (4.2 cm inner diameter). An additional 200 mL of 
hexane/ethyl acetate 9:1 mixture was used to elute the product off silica gel. The resulting red-
orange filtrate was concentrated down on a rotary evaporator, diluted with 60 mL of hexane and 
allowed to crystallize at room temperature (3 h) and then in a refrigerator overnight at −15 °C. The 
resulting solid crystalline mass was broken down, filtered off, and rinsed with 10-15 mL of cold 
hexane to give 24.1 g of off-white, crystalline product (64% yield) with mp 63-64 °C. Additional 
recrystallization from hexane raised the mp to 65-67 °C. 
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3.04a, R= Me,Ar = phenyl: previously reported.7 
3.04b, R= Me,Ar = 4-t-BuC6H4: previously reported.1b  
3.04c, R= Me, Ar = 1-naphthyl: White solid; mp: 117°C-120°C. 1H NMR (300 MHz, CDCl3): δ 
8.27 (d, J=8.0 Hz, 1H), 7.90 (d, J=8.0 Hz, 1H), 7.74 (d, J=8.0 Hz, 1H), 7.54 (m, 2H), 
7.38 (t, J=8.0 Hz, 1H), 7.23 (t, J=7.0 Hz, 1H), 7.03 (s, 1H), 6.87 (s, 1H), 4.90 (q, J=7.0 Hz, 
1H), 3.25 (br, s, 2H), 2.30 (s, 3H), 2.14 (s, 3H), δ 1.74 (d, J =7.0 Hz, 3H). 13C NMR (300 MHz, 
CDCl3): δ 141.94, 139.74, 134.18, 131.60, 130.05, 129.34, 129.27, 127.22, 126.49, 126.05, 
26.00, 125.73, 124.29, 123.17, 122.72, 35.50, 21.33, 21.00, 17.90. IR (KBr, cm-1): 3453, 3376, 
3047, 3004, 2967, 2930, 2914, 2871, 1625, 1604, 1596, 1578, 1509, 1484, 1446. MS: HR-ESI 
calculated for [(C20H21N)+H]+: 276.1753, found: 276.1747.  
3.04d, R= Me, Ar = 2-naphthyl: Pale brown oil; 1H NMR (300 MHz, CDCl3): δ 7.85-7.73 (m, 
3H), 7.69 (s, 1H), 7.49-7.41(m, 2H), 7.34 (d, J=9.0 Hz, 1H), 7.05 (s, 1H), 6.87 (s, 1H), 4.26 (q, 
J=7.0 Hz, 1H), 3.35 (br, s, 2H), 2.32 (s, 3H), 2.12 (s, 3H), 1.72 (d, J= 7.0 Hz, 3H). 13C NMR (300 
MHz, CDCl3): δ 143.41, 140.33, 133.66, 132.32, 129.47, 129.02, 128.51, 127.70, 127.65, 26.87, 
126.41, 126.03, 125.97, 125.50, 125.36, 22.63, 40.59, 21.87, 20.89, 17.64. IR (KBr, cm-1): 3450, 
3374, 3222, 3053, 3007, 2966, 2929, 2243, 1920, 1626, 1601, 1506, 1483, 1445, 1375, 
1298, 1266. MS: HR-ESI calculated for [(C20H21N)+H]+: 276.1747, found: 276.1743.  
3.04e, R= Me, Ar = 2,4,6-Me3C6H2: previously reported.1b  
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3.04f, R= Me, Ar = 2-MeC6H4: Beige solid; mp: 77°C-79°C. 1H NMR (300 MHz, CDCl3): δ 
7.19-7.05 (m, 3H), δ 7.04-6.97 (m, 1H), 6.93 (s, 1H), 6.82 (s, 1H), 4.21 (q, J=7.0 Hz, 1H), 3.32 
(br, s, 2H), 2.42 (s, 3H), 2.27 (s, 3H), 2.12 (s, 3H), 1.54 (d, J=7.0 Hz, 3H). 13C NMR (300 MHz, 
CDCl3): δ 143.89, 139.76, 135.62, 130.57, 129.90, 27.08, 126.73, 126.65, 126.39, 125.83, 
122.59, 36.34, 20.90, 20.56, 19.32, 17.77. IR (KBr, cm-1): 3447, 3370, 3062, 3042, 3015, 2928, 
2963, 2871, 1625, 1604, 1484, 1460. MS: HR-ESI calculated for [(C17H21N)+H]+ : 240.1747, 
found: 240.1750.  
3.04g, R= Me, Ar = 2-MeOC6H4: Pale pink solid; mp: 74°C-76°C. 1H NMR (300 MHz, CDCl3): 
δ 7.16 (t, J=9.0 Hz, 1H), 7.06 (s, 1H), 7.02 (d, J=8.0 Hz, 1H), 6.87 (t, J=8.0 Hz, 2H),  6.81 (s, 1H), 
δ 4.55 (q, J=7.0 Hz, 1H), 3.91 (s, 3H), 3.52 (br, s, 2H), 2.29 (s, 3H), 2.10 (s, 3H), δ 1.55 (d, 
J=7.0 Hz, 3H). 13C NMR (300 MHz, CDCl3): δ 156.37, 140.04, 134.21, 129.76, 129.04, 128.06, 
127.27, 126.72, 125.42, 122.26, 121.29, 10.41, 55.67, 31.51, 21.06, 20.95, 17.90. IR (KBr, cm-1): 
3461, 3384, 3061, 3024, 3001, 2965, 2931, 2874, 2835, 1627, 1598, 1584, 1488, 1462, 1438, 1375, 
1334, 1264, 1288, 1238. MS: HR-ESI calculated for [(C17H21NO)+H]+: 256. 1696, found 
256.1698.  
3.04h, R= Br,Ar = Phenyl: White solid; mp: 93-95°C. 1H NMR (300 MHz, CDCl3): δ 7.32-7.27 
(m, 3H), 7.23-7.18 (s, 3H), 7.13 (s, 1H), 4.02 (q, J=6.9 Hz, 1H), 3.43 (s, 2H), 2.09 (s, 3H), δ 1.60 
(d, J=6.9 Hz, 3H). 13C NMR (300 MHz, CDCl3): δ 145.9, 141.8, 131.2, 131.1, 129.0, 128.0, 127.5, 
126.8, 124.7, 110.2, 40.6, 22.2, 17.7.IR (cm-1): 3485, 3398, 2968, 1617, 1491, 1469, 1440, 1340, 
1256, 1216, 1055, 1028, 1001, 931, 863, 756, 703, 577, 550, 497. MS: HR-ESI calculated for 
[(C15H16BrN)+H]+: 290.0539, found 290.0539.  
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3.04i, R= Cl,Ar = Phenyl: Brown solid; mp: 87-90°C. 1H NMR (300 MHz, CDCl3): δ7.32-7.27 
(m, 2H), 7.23-7.20 (s, 4H), 6.99 (s, 1H), 4.03 (q, J=6.9 Hz, 1H), 3.47 (s, 2H), 2.10 (s, 3H), 1.60 
(d, J=6.9 Hz, 3H).13C NMR (300 MHz, CDCl3): δ 145.2, 141.1, 130.9, 129.1, 128.4, 127.6, 126.8, 
125.2, 124.4, 123.0, 40.6, 22.3, 17.8.IR (cm-1): 3487, 3399, 2968, 1618, 1490, 1470, 1441, 1340, 
1255, 1218, 1055, 1028, 1001, 866, 761, 703, 640, 576, 536, 503.MS: HR-ESI calculated for 
[(C15H16ClN)+H]+: 246.1044, found 246.1052.  
 
 
3.06a, R = Me, Ar = phenyl: previously reported.1b  
3.06b, R = Me, Ar = 4-t-BuC6H4: previously reported.1b  
3.06c, R = Me, Ar = 2,4,6-Me3C6H2: previously reported.1b  
3.06d, R = Me, Ar = 2-naphthyl: previously reported.1b  
3.06e, R = OMe, Ar = phenyl: previously reported.7  
3.06f, R = Cl, Ar = phenyl: previously reported.1c  
3.07a, R = Me, Ar = phenyl: Inseparable mixture of diastereomers. Previously reported.1b  
3.07b, R = Me, Ar = 4-t-BuC6H4: Inseparable mixture of diastereomers. Previously reported.1b 
3.07c, R = Me, Ar = 2,4,6-Me3C6H2: Separable diastereomers. Previously reported.1b  
3.07d, R = Me, Ar = 2-naphthyl: Separable diastereomers. Previously reported.1b 
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3.07e, R = OMe, Ar = phenyl: Separable diastereomers. High-Rf diastereomer: Dark red oil; 1H 
NMR (300 MHz, CDCl3): δ 7.35-7.05 (m, 10H), 6.86 (s, 2H), 4.01 (q, J=7.0 Hz, 2H), 3.82 (s, 3H), 
δ 3.07 (br, s, 2H), δ 1.58 (d, J=7.0 Hz, 6H). 13 C NMR (300 MHz, CDCl3): δ 
152.52, 145.79, 136.07, 131.69, 128.89 (2C), 127.56 (2C), 126.52, 111.54, 55.91, 
40.74, 22.51. IR (KBr, cm-1): 3353, 3070, 3080, 3059, 3024, 2965, 2933, 2872, 2831, 1601, 1491, 
1467, 1450, 1436, 1372, 1338, 1325, 1288, 1223, 1151, 1089, 1057, 1039, 1028. MS: HR-ESI 
calculated for [(C23H25NO)+Na]+: 354.1828, found: 354.1833. Low-Rf diastereomer: Dark red 
oil; 1H NMR (300 MHz, CDCl3): δ 7.25-7.08 (m, 10H), 6.81 (s, 2H), 4.07 (q, J=7.0 Hz, 2H), 3.80 
(s, 3H), 3.01 (br, s, 2H), 1.59 (d, J=7.0 Hz, 6H). 13C NMR (300 MHz, CDCl3): δ 
152.60, 145.61, 136.21, 131.63, 128.83 (2C), 127.59 (2C), 126.55, 111.61, 55.87, 
40.41, 22.40.  IR (KBr, cm-1): 3368, 3436, 3080, 3051, 3024, 2966, 2933, 2872, 2831, 1601, 1491, 
1469, 1450, 1322, 1221, 1150. MS: HR-ESI calculated for [(C23H25NO)+H]+: 332.2009, found: 
332.2014.  
3.07f, R = Cl, Ar = phenyl: Inseparable mixture of diastereomers. Yellow oil; 1H NMR (300 
MHz, CDCl3): δ 7.28-7.10 (m, 24H), 3.99 (q1, J=7.0 Hz, 2H, major diastereomer), 3.93 (q2, 
J=7.0 Hz, 2H, minor diastereomer), 3.34 (br, s, 4H), 1.58 (d, J=7.0 Hz, 12H). 13C NMR (300 
MHz, CDCl3): δ 145.00, 144.76, 141.05, 140.86, 131.48 (2C), 131.31 (2C), 128.86, 128.84, 
127.34, 126.66, 126.63, 125.59, 125.42, 123.25, 123.09, 40.44, 40.18, 22.40, 22.14. IR (KBr, cm-
1): 3454, 3382, 3080, 3060, 3024, 2968, 2933, 2908, 2873, 1882, 1622, 1601, 1490, 1463, 1444, 
1374, 1339, 1244, 1205, 1059, 1028. MS: HR-ESI calculated for [(C22H22NCl)+H]+: 336.1514, 
found: 336.1504.  
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Ch2-204nm  
Results 
    
Retention Time Area Area % Height Height % 
67.425 27904556 49.21 112718 52.74 
77.742 28801891 50.79 101018 47.26 
Totals 56706447 100.00 213736 100.00 
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SPD-10Avp 
Ch2-204nm 
Results 
    
Retention Time Area Area % Height Height % 
72.233 709906 3.22 3907 5.12 
79.067 21339712 96.78 72400 94.88 
Totals 22049618 100.00 76307 100.00 
 
HPLC condition: 5% isopropanol in hexane-ODH column. Catalyst 1.78 used. 
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Results 
    
Retention Time Area Area % Height Height % 
67.425 27904556 49.21 112718 52.74 
77.742 28801891 50.79 101018 47.26 
Totals 56706447 100.00 213736 100.00 
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SPD-10Avp 
Ch2-204nm 
Results 
    
Retention Time Area Area % Height Height % 
65.533 7526309 61.62 33857 63.49 
76.100 4687290 38.38 19470 36.51 
Totals 12213599 100.00 53327 100.00 
 
HPLC condition: 5% isopropanol in hexane-ODH column. Catalyst 1.86 used. 
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Ch1-254nm 
Results 
    
Retention 
Time 
Area Area % Height Height % 
47.425 8257898 45.78 37942 57.04 
58.708 9780056 54.22 28576 42.96 
Totals 18037954 100.00 66518 100.00 
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Results 
    
Retention 
Time 
Area Area % Height Height % 
51.958 262331 3.96 1910 8.77 
59.342 6363931 96.04 19861 91.23 
Totals 6626262 100.00 21771 100.00 
 
HPLC Condition: 3.3% Isopropanol in hexane-ODH column. 
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Results 
    
Retention Time Area Area % Height Height % 
19.583 4356992 50.45 77563 55.72 
22.342 4278465 49.55 61638 44.28 
Totals 8635457 100.00 139201 100.00 
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SPD-10Avp Ch1-
254nm Results 
    
Retention Time Area Area % Height Height % 
21.333 1000923 3.79 17312 5.58 
23.558 25415730 96.21 292821 94.42 
Totals 26416653 100.00 310133 100.00 
 
HPLC Condition: 5% Isopropanol in hexane-ODH column. 
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SPD-10Avp 
Ch2-204nm 
Results 
    
Retention Time Area Area % Height Height % 
44.417 16261410 47.94 97762 51.61 
64.750 17661897 52.06 91654 48.39 
Totals 33923307 100.00 189416 100.00 
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SPD-10Avp 
Ch2-204nm 
Results 
    
Retention Time Area Area % Height Height % 
46.825 516428 3.09 4209 4.73 
65.358 16222335 96.91 84765 95.27 
Totals 16738763 100.00 88974 100.00 
 
HPLC Condition: 5% Isopropanol in hexane-ODH column. 
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SPD-10Avp 
Ch1-254nm  
Results 
    
Retention Time Area Area % Height Height % 
9.467 7065689 50.23 179110 55.61 
12.817 7000515 49.77 142964 44.39 
Totals 14066204 100.00 322074 100.00  
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SPD-10Avp 
Ch1-254nm 
Results 
    
Retention Time Area Area % Height Height % 
9.700 570887 3.47 15646 4.67 
12.658 15860323 96.53 319414 95.33 
Totals 16431210 100.00 335060 100.00 
 
HPLC condition: 20% isopropanol in hexane-ODH 
131 
 
 
1
.9
0
 
132 
 
 
1
.9
0
 
133 
 
Minutes
0 20 40 60 80 100
V
o
lt
s
0
10
20
V
o
lt
s
0
10
20
6
3
.2
5
8
7
7
.1
9
2
SPD-10Avp Ch1-254nm
Retention Time
 
SPD-10Avp 
Ch1-254nm 
Results 
    
Retention 
Time 
Area Area % Height Height 
% 
63.258 4604271 51.74 19387 56.57 
77.192 4295039 48.26 14881 43.43 
Totals 8899310 100.00 34268 100.00 
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Results 
    
Retention 
Time 
Area Area % Height Height 
% 
68.367 841116 8.66 3322 12.79 
82.992 8874091 91.34 22647 87.21 
Totals 9715207 100.00 25969 100.00 
 
HPLC condition: 2.5% isoproponal in hexane-ADH column. Catalyst 1.88 used. 
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Results 
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63.258 4604271 51.74 19387 56.57 
77.192 4295039 48.26 14881 43.43 
Totals 8899310 100.00 34268 100.00 
Minutes
0 20 40 60 80 100
V
o
lt
s
0
25
50
V
o
lt
s
0
25
50
6
6
.8
2
5
7
9
.9
2
5
SPD-10Avp Ch1-254nm
Retention Time
 
SPD-10Avp 
Ch1-254nm 
Results 
    
Retention 
Time 
Area Area % Height Height 
% 
66.825 5317509 20.20 21011 28.68 
79.925 21008251 79.80 52247 71.32 
Totals 26325760 100.00 73258 100.00 
 
HPLC condition: 2.5% isoproponal in hexane-ADH column. Catalyst 1.86 used. 
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Results 
   2.27a 
Retention Time Area Area % Height Height % 
7.025 1527428 49.76 111944 55.39 
8.825 1542388 50.24 90159 44.61 
Totals 3069816 100.00 202103 100.00 
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SPD-10Avp 
Ch1-254nm 
Results 
    
Retention Time Area Area % Height Height % 
7.008 2490122 99.34 182235 99.46 
8.808 16624 0.66 989 0.54 
Totals 2506746 100.00 183224 100.00 
 
HPLC condition: 1% isopropanol in hexane, ODH column. 
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Results 
    
Retention Time Area Area % Height Height % 
18.317 14832099 46.81 354835 51.82 
21.500 16855196 53.19 329934 48.18 
Totals 31687295 100.00 684769 100.00 
Minutes
0 5 10 15 20 25 30
m
V
o
lt
s
0
250
500
750
m
V
o
lt
s
0
250
500
750
SPD-10Avp Ch2-204nm
 
SPD-10Avp 
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Results 
    
Retention Time Area Area % Height Height % 
18.342 42421892 99.12 821315 100.00 
21.483 375165 0.88 0 0.00 
Totals 42797057 100.00 821315 100.00 
 
HPLC condition: 1% isopropanol in hexane, ODH column. 
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SPD-10Avp 
Ch1-254nm 
Results 
   (Ra,S)-2.28a 
Retention Time Area Area % Height Height % 
9.083 1149764 49.49 56708 54.71 
10.908 1173273 50.51 46946 45.29 
Totals 2323037 100.00 103654 100.00 
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SPD-10Avp 
Ch1-254nm 
Results 
    
Retention Time Area Area % Height Height % 
9.333 2691 0.23 125 0.27 
11.025 1163488 99.77 45759 99.73 
Totals 1166179 100.00 45884 100.00 
 
HPLC condition: 1% isopropanol in hexane, ODH column. 
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SPD-10Avp 
Ch1-254nm 
Results 
   2.27b 
Retention Time Area Area % Height Height % 
6.017 1441275 47.09 252535 90.36 
7.875 1619299 52.91 26956 9.64 
Totals 3060574 100.00 279491 100.00 
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SPD-10Avp 
Ch1-254nm 
Results 
    
Retention Time Area Area % Height Height % 
6.117 8087337 98.70 1010916 99.75 
7.742 106459 1.30 2562 0.25 
Totals 8193796 100.00 1013478 100.00 
 
 
HPLC condition: 0.5% isopropanol in hexane, ODH column. 
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Ch2-204nm 
Results 
   (Sa,S)-2.28b  
Retention Time Area Area % Height Height %  
11.833 5538098 51.52 119177 59.02  
16.300 5212059 48.48 82749 40.98  
Totals 10750157 100.00 201926 100.00  
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SPD-10Avp 
Ch2-204nm 
Results 
    
Retention Time Area Area % Height Height % 
12.008 28289 0.11 881 0.24 
15.900 26071934 99.89 366186 99.76 
Totals 26100223 100.00 367067 100.00 
 
HPLC condition: 1% isopropanol in hexane, ADH column. 
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SPD-10Avp 
Ch1-254nm 
Results 
   (Ra,S)-2.28b 
 
Retention Time Area Area % Height Height % 
7.175 847798 49.73 49942 51.45 
8.125 856976 50.27 47128 48.55 
Totals 1704774 100.00 97070 100.00 
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SPD-10Avp 
Ch1-254nm 
Results 
    
Retention Time Area Area % Height Height % 
7.258 19372 0.63 1348 0.81 
8.083 3071835 99.37 165124 99.19 
Totals 3091207 100.00 166472 100.00 
 
HPLC condition: 1% isopropanol in hexane, ODH column. 
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Results 
   2.27c 
Retention Time Area Area % Height Height % 
13.858 2134841 50.49 71908 58.01 
18.558 2093365 49.51 52057 41.99 
Totals 4228206 100.00 123965 100.00 
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SPD-10Avp 
Ch1-254nm 
Results 
    
Retention Time Area Area % Height Height % 
13.842 6047743 99.49 203068 99.60 
18.708 31246 0.51 820 0.40 
Totals 6078989 100.00 203888 100.00 
 
 
HPLC condition: 1% isopropanol in hexane, ODH column. 
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SPD-10Avp 
Ch2-204nm 
Results 
   (Sa,S)-2.28c 
Retention Time Area Area % Height Height % 
13.800 3379773 53.81 93659 66.46 
24.833 2900809 46.19 47264 33.54 
Totals 6280582 100.00 140923 100.00 
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SPD-10Avp 
Ch1-204nm 
Results 
    
Retention Time Area Area % Height Height % 
14.400 57204 1.28 660 0.90 
23.925 4412358 98.72 72383 99.10 
Totals 4469562 100.00 73043 100.00 
HPLC condition: 5% isopropanol in hexane, ODH column. 
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(Ra,S)-2.28c 
SPD-10Avp 
Ch2-204nm 
Results 
    
Retention Time Area Area % Height Height % 
8.208 7320192 49.78 402687 58.53 
10.525 7384901 50.22 285299 41.47 
Totals 14705093 100.00 687986 100.00 
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SPD-10Avp 
Ch2-204nm 
Results 
    
Retention Time Area Area % Height Height % 
8.117 196296 0.49 11066 0.81 
10.250 40259942 99.51 1358212 99.19 
Totals 40456238 100.00 1369278 100.00 
 
HPLC condition: 5% isopropanol in hexane, ODH column. 
158 
 
Minutes
0 2 4 6 8 10 12 14
V
o
lt
s
0
20
40
V
o
lt
s
0
20
40
9
.3
7
5
1
1
.8
7
5
SPD-10Avp Ch1-254nm
Retention Time
  
SPD-10Avp 
Ch1-254nm 
Results 
   2.27d 
Retention Time Area Area % Height Height % 
9.375 793308 59.93 45184 65.53 
11.875 530419 40.07 23763 34.47 
Totals 1323727 100.00 68947 100.00 
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SPD-10Avp 
Ch1-254nm 
Results 
    
Retention Time Area Area % Height Height % 
8.992 3848463 99.29 221970 99.43 
11.350 27379 0.71 1264 0.57 
Totals 3875842 100.00 223234 100.00 
 
 
HPLC condition: 5% isopropanol in hexane, ODH column. 
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Results 
   (Sa,S)-2.28d 
Retention Time Area Area % Height Height % 
31.667 7502648 49.90 58568 60.91 
42.850 7533901 50.10 37581 39.09 
Totals 15036549 100.00 96149 100.00 
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SPD-10Avp 
Ch1-254nm 
Results 
    
Retention Time Area Area % Height Height % 
32.633 304583 0.66 2001 0.93 
44.683 45777761 99.34 213612 99.07 
Totals 46082344 100.00 215613 100.00 
 
HPLC condition: 1% isopropanol in hexane, ADH column. 
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Results 
   (Ra,S)-2.28d 
Retention Time Area Area % Height Height % 
12.017 1740408 50.44 54012 69.83 
18.233 1709943 49.56 23339 30.17 
Totals 3450351 100.00 77351 100.00 
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SPD-10Avp 
Ch1-254nm 
Results 
    
Retention Time Area Area % Height Height % 
12.133 37553 0.87 818 1.54 
17.958 4292135 99.13 52221 98.46 
Totals 4329688 100.00 53039 100.00 
 
HPLC condition: 1% isopropanol in hexane, ODH column. 
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SPD-10Avp 
Ch1-254nm 
Results 
    
Retention Time Area Area % Height Height % 
16.500 2368789 50.40 39848 59.42 
23.575 2330876 49.60 27216 40.58 
Totals 4699665 100.00 67064 100.00 
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SPD-10Avp 
Ch1-254nm 
Results 
    
Retention Time Area Area % Height Height % 
15.075 81664 2.79 2049 4.81 
21.508 2842660 97.21 40579 95.19 
Totals 2924324 100.00 42628 100.00 
 
HPLC condition: 1% isopropanol in hexane, ADH column. 
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Results 
   (Sa,S)-2.28e 
Retention Time Area Area % Height Height % 
13.550 1053311 45.78 29319 57.95 
20.767 1247348 54.22 21274 42.05 
Totals 2300659 100.00 50593 100.00 
 
Minutes
0 5 10 15 20 25
V
o
lt
s
0
50
100
V
o
lt
s
0
50
100
1
3
.6
6
7
2
0
.5
9
2
SPD-10Avp Ch1-254nm
Retention Time
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Results 
    
Retention 
Time 
Area Area % Height Height % 
13.667 16013 0.30 456 0.46 
20.592 5328419 99.70 97854 99.54 
Totals 5344432 100.00 98310 100.00 
     
HPLC condition: 1% isopropanol in hexane, ODH column. 
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Results 
   (Ra,S)-2.28e 
Retention Time Area Area % Height Height % 
17.383 132884 49.69 3077 53.36 
20.083 134567 50.31 2689 46.64 
Totals 267451 100.00 5766 100.00 
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SPD-10Avp 
Ch2-204nm 
Results 
    
Retention Time Area Area % Height Height % 
14.808 55264268 93.48 1205057 94.19 
20.900 3853815 6.52 74327 5.81 
Totals 59118083 100.00 1279384 100.00 
 
 
HPLC condition: 1% isopropanol in hexane, ODH column.   
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Results 
   (R)-2.33 
Retention Time Area Area % Height Height % 
16.225 316486 50.00 5083 56.30 
20.492 316451 50.00 3945 43.70 
Totals 632937 100.00 9028 100.00 
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SPD-10Avp 
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Results 
    
Retention Time Area Area % Height Height % 
17.025 2435934 65.01 37021 69.95 
21.542 1311002 34.99 15901 30.05 
Totals 3746936 100.00 52922 100.00 
 
 
HPLC condition: 10% isopropanol in hexane, ADH column. 
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Results 
   (S)-2.33 
Retention Time Area Area % Height Height % 
12.742 53724517 48.64 1721659 55.83 
19.217 56736734 51.36 1362101 44.17 
Totals 110461251 100.00 3083760 100.00 
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SPD-10Avp 
Ch1-254nm 
Results 
    
Retention Time Area Area % Height Height % 
12.317 1908975 87.27 76483 91.04 
18.417 278465 12.73 7523 8.96 
Totals 2187440 100.00 84006 100.00 
 
HPLC condition: 10% isopropanol in hexane, ODH column. 
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